Equitable Financial Life Insurance 10-Q 14 May 19 2019 Q1 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - shares	3 Months Ended
	Mar. 31, 2019	May 13, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019
Amendment Flag	false
Entity Registrant Name	AXA EQUITABLE LIFE INSURANCE CO
Entity Central Index Key	0000727920
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock Shares Outstanding		2,000,000

CONSOLIDATED BALANCE SHEET (UNA

CONSOLIDATED BALANCE SHEET (UNAUDITED) - USD ($) $ in Millions		Mar. 31, 2019	Dec. 31, 2018
ASSETS
Fixed maturities available-for-sale, at fair value (amortized cost of $44,926 and $42,492)		$ 45,929	$ 41,915
Mortgage loans on real estate (net of valuation allowance of $0 and $7)		12,100	11,818
Real estate held for production of income	[1]	68	52
Policy loans		3,253	3,267
Other equity investments	[1]	1,129	1,144
Trading securities, at fair value		12,704	15,166
Other invested assets		1,749	1,554
Total investments		76,932	74,916
Cash and cash equivalents		2,922	2,622
Deferred policy acquisition costs		4,338	5,011
Amounts due from reinsurers		3,093	3,124
Loans to affiliates		600	600
GMIB reinsurance contract asset, at fair value		2,009	1,991
Current and deferred income taxes		184	438
Other assets		3,031	2,763
Separate Accounts assets		118,130	108,487
Total Assets		211,239	199,952
LIABILITIES
Policyholders’ account balances		48,593	46,403
Future policy benefits and other policyholders' liabilities		30,294	29,808
Broker-dealer related payables		147	69
Securities sold under agreements to repurchase		0	573
Amounts due to reinsurers		57	113
Loans from affiliates		0	572
Other liabilities		1,600	1,460
Separate Accounts liabilities		118,130	108,487
Total Liabilities		198,821	187,485
Redeemable noncontrolling interest		48	39
Commitments and contingent liabilities (Note 12)
Equity attributable to AXA Equitable:
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding		2	2
Additional paid-in capital		7,815	7,807
Retained earnings		4,268	5,098
Accumulated other comprehensive income (loss)		273	(491)
Total AXA Equitable’s equity		12,358	12,416
Noncontrolling interest		12	12
Total equity		12,370	12,428
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 211,239	$ 199,952
[1]	See Note 2 for details of balances with variable interest entities

CONSOLIDATED BALANCE SHEET (U_2

CONSOLIDATED BALANCE SHEET (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Fixed maturities available-for-sale, amortized cost	$ 44,926	$ 42,492
Mortgage loans on real estate, valuation allowances	$ 0	$ 7
Common stock par value (in dollars per share)	$ 1.25	$ 1.25
Common stock authorized (in shares)	2,000,000	2,000,000
Common stock issued (in shares)	2,000,000	2,000,000
Common stock outstanding (in shares)	2,000,000	2,000,000

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
REVENUES
Policy charges and fee income		$ 859	$ 861
Premiums		232	223
Net derivative gains (losses)		(1,555)	(817)
Net investment income (loss)		904	509
Investment gains (losses), net		(8)	87
Investment management and service fees		248	254
Other income		10	22
Total revenues		690	1,139
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits		819	480
Interest credited to policyholders’ account balances		269	255
Compensation and benefits		82	149
Commissions		157	160
Interest expense		4	9
Amortization of deferred policy acquisition costs		165	209
Other operating costs and expenses		184	250
Total benefits and other deductions		1,680	1,512
Income (loss) from continuing operations, before income taxes		(990)	(373)
Income tax (expense) benefit from continuing operations		162	80
Net income (loss) from continuing operations			(293)
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest		0	29
Net income (loss)		(828)	(264)
Net income (loss)	[1]	(828)	(109)
Less: Net (income) loss attributable to the noncontrolling interest		(2)	1
Net income (loss) attributable to AXA Equitable		$ (830)	$ (263)
[1]	Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss).

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (828)	$ (264)
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment	764	(742)
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	0	(4)
Other comprehensive income (loss) from discontinued operations	0	(10)
Total other comprehensive income (loss), net of income taxes	764	(756)
Comprehensive income (loss) attributable to AXA Equitable	$ (64)	$ (1,020)

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) $ in Millions	Total	AXA Equitable Equity	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Continuing OperationsNoncontrolling Interest	Discontinued OperationsNoncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption of revenue recognition standard ASC 606 | Accounting Standards Update 2014-09	$ 33	$ 8			$ 8		$ 25		$ 25
Beginning of year at Dec. 31, 2017	19,492	16,397	$ 2	$ 6,859	8,938	$ 598	3,095	$ 19	3,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deconsolidation of real estate joint ventures	(8)						(8)	(8)
Repurchase of AB Holding units	(2)						(2)		(2)
Dividends paid to noncontrolling interest	(176)						(176)		(176)
Net income (loss)	(129)	(263)			(263)		134	1	133
Other comprehensive income (loss)	(749)	(756)				(756)	7		7
Other	31	18		18			13		13
End of year at Mar. 31, 2018	18,492	15,404	2	6,877	8,683	(158)	3,088	12	3,076
Beginning of year at Dec. 31, 2018	12,428	12,416	2	7,807	5,098	(491)	12	12	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(830)	(830)			(830)
Other comprehensive income (loss)	764	764				764
Other	8	8		8
End of year at Mar. 31, 2019	$ 12,370	$ 12,358	$ 2	$ 7,815	$ 4,268	$ 273	$ 12	$ 12	$ 0

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	[1]	$ (828)	$ (109)
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		269	255
Policy charges and fee income		(859)	(861)
Net derivative (gains) losses		1,555	815
Investment (gains) losses, net		8	(87)
Realized and unrealized (gains) losses on trading securities		(250)	63
Non-cash long-term incentive compensation expense		8	12
Amortization and depreciation	[2]	143	201
Amortization of deferred cost of reinsurance asset		0	46
Equity (income) loss from limited partnerships	[2]	(11)	(39)
Changes in:
Net broker-dealer and customer related receivables/payables		0	283
Reinsurance recoverable		(97)	(147)
Segregated cash and securities, net		0	(208)
Capitalization of deferred policy acquisition costs	[2]	(145)	(135)
Future policy benefits		41	(198)
Current and deferred income taxes		54	80
Other, net		(36)	12
Net cash provided by (used in) operating activities		(148)	(17)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale		2,662	3,238
Mortgage loans on real estate		216	68
Trading account securities		3,376	1,683
Real estate joint ventures		1	140
Short-term investments	[2]	747	688
Other		41	(86)
Payment for the purchase/origination of:
Fixed maturities, available-for-sale		(5,065)	(2,313)
Mortgage loans on real estate		(517)	(447)
Trading account securities		(518)	(2,595)
Short-term investments	[2]	(681)	(377)
Other		(62)	(48)
Cash settlements related to derivative instruments		(978)	(503)
Investment in capitalized software, leasehold improvements and EDP equipment		(13)	(24)
Other, net		97	(407)
Net cash provided by (used in) investing activities		(694)	(983)
Policyholders’ account balances:
Deposits		2,271	1,898
Withdrawals		(1,048)	(1,081)
Transfers (to) from Separate Accounts		445	452
Change in short-term financings		0	(76)
Change in collateralized pledged assets		(6)	(5)
Change in collateralized pledged liabilities		625	(31)
Increase (decrease) in overdrafts payable		0	7
Repurchase of AB Holding Units		0	(2)
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds		0	373
Distribution to noncontrolling interests in consolidated subsidiaries		0	(176)
Repayment of loans from affiliates		(572)	0
Increase (decrease) in securities sold under agreement to repurchase		(573)	17
Other, net		0	4
Net cash provided by (used in) financing activities		1,142	1,380
Effect of exchange rate changes on cash and cash equivalents		0	8
Change in cash and cash equivalents		300	388
Cash and cash equivalents, beginning of year		2,622
Cash and cash equivalents, end of period		2,922	3,797
Cash and cash equivalents of disposed subsidiary:
Beginning of year			1,009
End of period			1,235
Cash and cash equivalents of continuing operations
Beginning of year		2,622	3,409
End of period		2,922	3,797
Cash flows of disposed subsidiary:
operating activities			274
investing activities			(182)
financing activities			126
Effect of exchange rate changes on cash and cash equivalents			8
Non-cash transactions during the period
(Settlement) issuance of long-term debt	[1]		(202)
Transfer of assets to reinsurer	[1]		$ (604)
[1]	Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss).
[2]	Prior period amounts have been reclassified to conform to the current period’s presentation. See Note 14 for further information.

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net (income) loss attributable to the noncontrolling interest	$ 2	$ (1)
Alliance Bernstein | Discontinued Operations
Net (income) loss attributable to the noncontrolling interest		$ 155

ORGANIZATION

ORGANIZATION	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	ORGANIZATION Consolidation AXA Equitable Life Insurance Company’s (“AXA Equitable” and, collectively with its consolidated subsidiaries, the “Company”) primary business is providing life insurance and employee benefit products to both individuals and businesses. The Company is an indirect, wholly-owned subsidiary of AXA Equitable Holdings, Inc. (“Holdings”). As of March 31, 2019 and December 31, 2018 , AXA S.A. (“AXA”), a French holding company for the AXA Group, owned approximately 48% and 59% , respectively, of the outstanding common stock of Holdings. The accompanying consolidated financial statements represent the consolidated results and financial position of AXA Equitable and not the consolidated results and financial position of Holdings. Discontinued Operations In the fourth quarter of 2018, the Company transferred its economic interest in the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”) to a newly created wholly-owned subsidiary of Holdings (the “AB Business Transfer”). See Note 13 for additional information.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Significant Accounting Policies	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Intercompany balances and transactions have been eliminated. In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The terms “ first quarter 2019 ” or “first three months of 2019 ” and “ first quarter 2018 ” or “first three months of 2018 ” refer to the three months ended March 31, 2019 and 2018 , respectively. Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2017-12: Derivatives and Hedging (Topic 815) The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. On January 1, 2019, the Company adopted the new hedging guidance. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. Description Effect on the Financial Statement or Other Significant Matters ASU 2017-08: Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. On January 1, 2019, the Company adopted the new guidance on accounting for certain premiums on callable debt securities. As the Company’s existing accounting practices aligned with the guidance in the ASU, adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. ASU 2016-02: Leases (Topic 842) This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. On January 1, 2019, the Company adopted the new leases standard using the simplified modified retrospective transition method, as of the adoption date. Prior comparable periods will not be adjusted or presented under this method. We applied several practical expedients offered by ACS 842 upon adoption of this standard. These included continuing to account for existing leases based on judgment made under legacy U.S. GAAP as it relates to determining classification of leases, unamortized initial direct costs and whether contracts are leases or contain leases. We also used the practical expedient to use hindsight in determining lease terms (using knowledge and expectations as of the standard’s adoption date instead of the previous assumptions under legacy U.S. GAAP) and evaluated impairment of our right-of-use (“RoU”) assets in the transition period (using most up-to-date information.) Adoption of this standard resulted in the recognition, as of January 1, 2019, of additional RoU operating lease assets of $347 million reported in Other assets and operating lease liabilities of $439 million reported in Other liabilities in accompanying consolidated balance sheets. The operating RoU assets recognized as of January 1, 2019 are net of deferred rent of $58 million and liabilities associated with previously recognized impairments of $34 million. See Note 8 for additional information. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU modify disclosure requirements in Topic 820, including the removal of certain disclosure requirements, modification of certain disclosures, and the addition of new requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional requirements delayed until their effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944) This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Effective for fiscal years beginning after December 31, 2020. Early adoption is permitted. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on our consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred policy acquisition costs. The ASU simplifies the amortization of deferred policy acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, Separate Accounts liabilities and deferred policy acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments - Credit Losses (Topic 326) This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Accounting and Consolidation of Variable Interest Entities (“VIEs”) At March 31, 2019 , the Company held $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are $168.6 billion at March 31, 2019 . The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.1 billion and $866 million of unfunded commitments at March 31, 2019 . The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. At March 31, 2019 , the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable Life Insurance Company (“AXA Equitable Life”) and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheet at March 31, 2019 related to this VIE is $35 million of Real estate held for production of income. In addition, Real estate held for production of income reflects $16 million as related to two non-consolidated joint ventures at March 31, 2019 . Assumption Updates and Model Changes In 2018, the Company began conducting its annual review of the Company’s assumptions and models during the third quarter, consistent with industry practice. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for the Company’s insurance business, liabilities for future policyholder benefits, deferred policy acquisition cost (“DAC”) and deferred sales inducement (“DSI”) assets. Accordingly, there were no material assumption changes in the first quarters of 2019 or 2018. Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company changed the presentation of the capitalization of DAC in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of DAC. There was no impact on Net income (loss) or Comprehensive income (loss) from this reclassification. The reclassification adjustments for the three months ended March 31, 2018 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item. Three Months Ended March 31, 2018 (in millions) Reductions to expense line items: Compensation and benefits $ 33 Commissions 101 Other operating costs and expenses 1 Total reductions $ 135 Increase to expense line item: Amortization of deferred policy acquisition costs $ 135 Revenue Recognition The table below presents the revenues recognized during the three months ended March 31, 2019 and 2018 , disaggregated by category: Three Months Ended March 31, 2019 2018 (in millions) Investment management and service fees: Base fees $ 178 $ 182 Distribution services 70 72 Total investment management and service fees $ 248 $ 254 Other income $ 5 $ 7 Revision of Prior Period Financial Statements D uring the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included in Note 14 on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. See Note 14 for further information.

INVESTMENTS

INVESTMENTS	3 Months Ended
	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Investments	INVESTMENTS Fixed Maturities The following tables provide information relating to fixed maturities classified as available-for-sale (“AFS”). Available-for-Sale Securities by Classification Amortized Gross Unrealized Gross Unrealized Fair OTTI (in millions) March 31, 2019: Fixed Maturities: Corporate (1) $ 30,106 $ 867 $ 208 $ 30,765 $ — U.S. Treasury, government and agency 12,719 462 213 12,968 — States and political subdivisions 408 55 — 463 — Foreign governments 478 27 7 498 — Residential mortgage-backed (2) 185 10 — 195 — Asset-backed (3) 608 1 4 605 2 Redeemable preferred stock 422 16 3 435 — Total at March 31, 2019 $ 44,926 $ 1,438 $ 435 $ 45,929 $ 2 December 31, 2018: Fixed Maturities: Corporate (1) $ 26,690 $ 385 $ 699 $ 26,376 $ — U.S. Treasury, government and agency 13,646 143 454 13,335 — States and political subdivisions 408 47 1 454 — Foreign governments 515 17 13 519 — Residential mortgage-backed (2) 193 9 — 202 — Asset-backed (3) 600 1 11 590 2 Redeemable preferred stock 440 16 17 439 — Total at December 31, 2018 $ 42,492 $ 618 $ 1,195 $ 41,915 $ 2 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in Net income (loss). The contractual maturities of AFS fixed maturities at March 31, 2019 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) March 31, 2019: Due in one year or less $ 1,817 $ 1,829 Due in years two through five 10,322 10,519 Due in years six through ten 14,953 15,367 Due after ten years 16,619 16,979 Subtotal 43,711 44,694 Residential mortgage-backed 185 195 Asset-backed 608 605 Redeemable preferred stock 422 435 Total at March 31, 2019 $ 44,926 $ 45,929 The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the three months ended March 31, 2019 and 2018 : Three Months Ended March 31, 2019 2018 (in millions) Proceeds from sales $ 1,361 $ 3,428 Gross gains on sales $ 8 $ 127 Gross losses on sales $ (15 ) $ (41 ) Total OTTI $ — $ — Non-credit losses recognized in OCI — — Credit losses recognized in Net income (loss) $ — $ — The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments Three Months Ended March 31, 2019 2018 (in millions) Balances at January 1, $ (46 ) $ (10 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 28 — Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired — — Additional impairments this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at March 31, $ (18 ) $ (10 ) ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: Net Unrealized Gains (Losses) on Fixed Maturities Classified as AFS March 31, 2019 December 31, 2018 (in millions) Fixed maturities available-for-sale: With OTTI loss $ — $ — All other 1,003 (577 ) Net unrealized gains (losses) $ 1,003 $ (577 ) Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net DAC Policyholders’ Deferred AOCI Gain (in millions) Balances at January 1, 2019 $ — $ — $ — $ — $ — Net investment gains (losses) arising during the period (10 ) — — — (10 ) Reclassification adjustment: Included in Net income (loss) 10 — — — 10 Impact of net unrealized investment gains (losses) on: DAC — — — — — Deferred income taxes — — — — — Policyholders’ liabilities — — — — — Balances at March 31, 2019 $ — $ — $ — $ — $ — Balances at January 1, 2018 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) Net investment gains (losses) arising during the period — — — — — Reclassification adjustment: Included in Net income (loss) (2 ) — — — (2 ) Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — — — Policyholders’ liabilities — — 1 — 1 Balances at March 31, 2018 $ (1 ) $ — $ — $ (5 ) $ (6 ) All Other Net Unrealized Investment Gains (Losses) in AOCI Net DAC Policyholders’ Deferred AOCI Gain (in millions) Balances at January 1, 2019 $ (577 ) $ 39 $ (55 ) $ 125 $ (468 ) Net investment gains (losses) arising during the period 1,583 — — — 1,583 Reclassification adjustment: — Included in Net income (loss) (3 ) — — — (3 ) Impact of net unrealized investment gains (losses) on: DAC — (655 ) — — (655 ) Deferred income taxes — — — (211 ) (211 ) Policyholders’ liabilities — — 77 — 77 Balances at March 31, 2019 $ 1,003 $ (616 ) $ 22 $ (86 ) $ 323 Balances at January 1, 2018 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 Net investment gains (losses) arising during the period (1,245 ) — — — (1,245 ) Reclassification adjustment: Included in Net income (loss) (88 ) — — — (88 ) Impact of net unrealized investment gains (losses) on: DAC — 288 — — 288 Deferred income taxes — — — 197 197 Policyholders’ liabilities — — 108 — 108 Balances at March 31, 2018 $ 193 $ (27 ) $ (124 ) $ (103 ) $ (61 ) The following tables disclose the fair values and gross unrealized losses of the 674 issues at March 31, 2019 and the 1,471 issues at December 31, 2018 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) March 31, 2019: Fixed Maturities: Corporate $ 653 $ 6 $ 5,387 $ 202 $ 6,040 $ 208 U.S. Treasury, government and agency — — 3,163 213 3,163 213 Foreign governments — — 67 7 67 7 Asset-backed 279 1 249 3 528 4 Redeemable preferred stock 44 1 35 2 79 3 Total at March 31, 2019 $ 976 $ 8 $ 8,901 $ 427 $ 9,877 $ 435 December 31, 2018: Fixed Maturities: Corporate $ 8,369 $ 306 $ 6,161 $ 393 $ 14,530 $ 699 U.S. Treasury, government and agency 2,636 68 3,154 386 5,790 454 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 13 — 13 — Asset-backed 558 11 6 — 564 11 Redeemable preferred stock 160 12 31 5 191 17 Total at December 31, 2018 $ 11,832 $ 400 $ 9,460 $ 795 $ 21,292 $ 1,195 The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.7% of total investments. The largest exposures to a single issuer of corporate securities held at March 31, 2019 and December 31, 2018 were $218 million and $210 million , respectively, representing 1.8% and 1.7% of the consolidated equity of the Company Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At March 31, 2019 and December 31, 2018 , respectively, approximately $1,250 million and $1,228 million , or 2.8% and 2.9% , of the $44,926 million and $42,492 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized losses of $5 million and $30 million at March 31, 2019 and December 31, 2018 , respectively. At March 31, 2019 and December 31, 2018 , respectively, the $427 million and $795 million of gross unrealized losses of twelve months or more were concentrated in corporate and U.S. Treasury, government and agency securities. In accordance with the policy described in Note 2 , the Company concluded that an adjustment to income for OTTI for the three months ended March 31, 2019 or 2018 for these securities was not warranted. At March 31, 2019 and December 31, 2018 , the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. At March 31, 2019 and December 31, 2018 , the fair value of the Company’s trading account securities was $12,704 million and $15,166 million , respectively. At March 31, 2019 and December 31, 2018 , trading account securities included the General Account’s investment in Separate Accounts which had carrying values of $50 million and $48 million , respectively. Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the Consolidated Statements of Income (Loss). The table below shows a breakdown of Net investment income (loss) from trading account securities during the three months ended March 31, 2019 and 2018 : Net Investment Income (Loss) from Trading Account Securities Three Months Ended March 31, 2019 2018 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ 274 $ (96 ) Net investment gains (losses) recognized on securities sold during the period (24 ) (1 ) Net investment gains (losses) on trading account securities arising during the period 250 (97 ) Interest and dividend income from trading account securities 90 66 Net investment income (loss) from trading account securities $ 340 $ (31 ) Mortgage Loans The payment terms of mortgage loans may from time to time be restructured or modified. At March 31, 2019 and December 31, 2018 , the carrying values of problem commercial mortgage loans on real estate that had been classified as non-accrual loans were $0 and $19 million , respectively. Valuation Allowances for Mortgage Loans: The change in the valuation allowance for credit losses for commercial mortgage loans during the three months ended March 31, 2019 and 2018 are as follows: Three Months Ended March 31, 2019 2018 (in millions) Allowance for credit losses: Beginning balance, January 1, $ 7 $ 8 Charge-offs (7 ) — Recoveries — (1 ) Provision — — Ending balance, March 31, $ — $ 7 March 31, Individually Evaluated for Impairment $ — $ 7 There were no allowances for credit losses for agricultural mortgage loans for the three months ended March 31, 2019 and 2018 . The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at March 31, 2019 and December 31, 2018 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Total Mortgage Loans Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x (in millions) March 31, 2019: Commercial Mortgage Loans 0% - 50% $ 764 $ 21 $ 215 $ 24 $ — $ — $ 1,024 50% - 70% 4,933 806 1,284 474 — — 7,497 70% - 90% 266 — 117 334 132 — 849 90% plus — — — — — — — Total Commercial Mortgage Loans $ 5,963 $ 827 $ 1,616 $ 832 $ 132 $ — $ 9,370 Agricultural Mortgage Loans 0% - 50% $ 278 $ 130 $ 276 $ 563 $ 350 $ 49 $ 1,646 50% - 70% 119 70 248 357 237 34 1,065 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 397 $ 200 $ 524 $ 939 $ 587 $ 83 $ 2,730 Total Mortgage Loans 0% - 50% $ 1,042 $ 151 $ 491 $ 587 $ 350 $ 49 $ 2,670 50% - 70% 5,052 876 1,532 831 237 34 8,562 70% - 90% 266 — 117 353 132 — 868 90% plus — — — — — — — Total Mortgage Loans $ 6,360 $ 1,027 $ 2,140 $ 1,771 $ 719 $ 83 $ 12,100 December 31, 2018: Commercial Mortgage Loans 0% - 50% $ 780 $ 21 $ 247 $ 24 $ — $ — $ 1,072 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,948 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,130 Agricultural Mortgage Loans 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans 0% - 50% $ 1,062 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,683 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,342 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,825 ______________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually. The following table provides information relating to the aging analysis of past due mortgage loans at March 31, 2019 and December 31, 2018 . Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) March 31, 2019 Commercial $ — $ — $ — $ — $ 9,370 $ 9,370 $ — Agricultural 9 26 55 90 2,640 2,730 54 Total Mortgage Loans $ 9 $ 26 $ 55 $ 90 $ 12,010 $ 12,100 $ 54 December 31, 2018 Commercial $ — $ — $ 27 $ 27 $ 9,103 $ 9,130 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,730 $ 11,825 $ 40 The following table provides information relating to impaired mortgage loans at March 31, 2019 and December 31, 2018 . Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) March 31, 2019: With no related allowance recorded: Agricultural mortgage loans $ 2 $ 2 $ — $ 2 $ — Total $ 2 $ 2 $ — $ 2 $ — With related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ 13 $ — Total $ — $ — $ — $ 13 $ — December 31, 2018: With no related allowance recorded: Agricultural mortgage loans $ 2 $ 2 $ — $ — $ — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Total $ 27 $ 31 $ (7 ) $ 27 $ — ______________ (1) Represents a two-quarter and five-quarter average of recorded amortized cost at March 31, 2019 and December 31, 2018 , respectively.

DERIVATIVES

DERIVATIVES	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES	DERIVATIVES The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the U.S. dollar or euro-equivalent of the derivative’s notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. In 2016, the Company implemented a program to mitigate its duration gap using total return swaps for which the reference U.S. Treasury securities are sold to the swap counterparty under arrangements economically similar to repurchase agreements. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. Under this program, the Company derecognized $3,905 million of U.S. Treasury securities for which the Company received proceeds of $3,905 million at inception of the total return swap contract. Under the terms of these swaps, the Company retains ongoing exposure to the total returns of the underlying U.S. Treasury securities in exchange for a financing cost. At March 31, 2019 , the aggregate fair value of U.S. Treasury securities derecognized under this program was $3,788 million . Reported in Other invested assets in the Company’s balance sheet at March 31, 2019 is $87 million , representing the fair value of the total return swap contracts. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At March 31, 2019 Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2019 Fair Value Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (2): Equity contracts: Futures $ 6,544 $ — $ — $ (738 ) Swaps 8,065 6 371 (973 ) Options 37,417 3,474 1,310 1,101 Interest rate contracts: Swaps 28,153 910 209 648 Futures 16,385 — — 55 Credit contracts: Credit default swaps 1,242 22 — 10 Other freestanding contracts: Foreign currency contracts 1,796 24 1 10 Margin — 16 — — Collateral — 9 2,556 — Embedded Derivatives (2): GMIB reinsurance contracts — 2,009 — 27 GMxB derivative features liability (3) — — 5,944 (409 ) SCS, SIO, MSO and IUL indexed features (4) — — 1,992 (1,286 ) Total $ 99,602 $ 6,470 $ 12,383 $ (1,555 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. At December 31, 2018 Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2018 Fair Value Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (2): Equity contracts: Futures $ 10,411 $ — $ — $ (29 ) Swaps 7,697 140 168 64 Options 21,698 2,119 1,163 (15 ) Interest rate contracts: Swaps 27,003 632 194 (490 ) Futures 11,448 — — 40 Credit contracts: Credit default swaps 1,282 17 — — Other freestanding contracts: Foreign currency contracts 2,097 27 14 (51 ) Margin — 7 5 — Collateral — 3 1,564 — Embedded Derivatives (2): GMIB reinsurance contracts — 1,991 — (842 ) GMxB derivative features liability (3) — — 5,431 485 SCS, SIO, MSO and IUL indexed features (4) — — 687 21 Total $ 81,636 $ 4,936 $ 9,226 $ (817 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at March 31, 2019 are exchange-traded and net settled daily in cash. At March 31, 2019 , the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000, and Emerging Market indices, having initial margin requirements of $256 million , (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $34 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200, and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $25 million . Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At March 31, 2019 and December 31, 2018 , respectively, the Company held $2,556 million and $1,564 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $9 million and $3 million at March 31, 2019 and December 31, 2018 , respectively, in the normal operation of its collateral arrangements. Securities Repurchase and Reverse Repurchase Transactions Securities repurchase and reverse repurchase transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit the requirements of each respective counterparty. The Company’s securities repurchase and reverse repurchase agreements are accounted for as secured borrowing or lending arrangements, respectively and are reported in the consolidated balance sheets on a gross basis. At March 31, 2019 and December 31, 2018 , the balance outstanding under securities repurchase transactions was $0 and $573 million , respectively. The Company utilized these repurchase and reverse repurchase agreements for asset liability and cash management purposes. For other instruments used for asset and liability management purposes, see Note 12 . The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2019 . Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total derivatives $ 4,460 $ 4,399 $ 61 Other financial instruments 1,688 — 1,688 Other invested assets $ 6,148 $ 4,399 $ 1,749 Liabilities Total derivatives $ 4,399 $ 4,352 $ 47 Other financial liabilities 1,553 — 1,553 Other liabilities $ 5,952 $ 4,352 $ 1,600 The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at March 31, 2019 . Collateral Amounts Not Offset in the Consolidated Balance Sheets At March 31, 2019 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash Net Amount (in millions) Assets Total derivatives $ 2,546 $ 367 $ 2,118 $ 61 Other financial instruments 1,688 — — 1,688 Other invested assets $ 4,234 $ 367 $ 2,118 $ 1,749 Liabilities Total derivatives $ 47 $ — $ — $ 47 Other financial liabilities 1,553 — — 1,553 Other liabilities $ 1,600 $ — $ — $ 1,600 The Company had no securities sold under agreements to repurchase at March 31, 2019 . The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2018 . Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total derivatives $ 2,946 $ 2,912 $ 34 Other financial instruments 1,520 — 1,520 Other invested assets $ 4,466 $ 2,912 $ 1,554 Liabilities Total derivatives $ 3,109 $ 2,912 $ 197 Other financial liabilities 1,263 — 1,263 Other liabilities $ 4,372 $ 2,912 $ 1,460 Securities sold under agreement to repurchase (1) $ 571 $ — $ 571 ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase. The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018 . Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash Net Amount (in millions) Assets Total derivatives $ 1,397 $ — $ (1,363 ) $ 34 Other financial instruments 1,520 — — 1,520 Other invested assets $ 2,917 $ — $ (1,363 ) $ 1,554 Liabilities Total derivatives $ 197 $ — $ — $ 197 Other financial liabilities 1,263 — — 1,263 Other liabilities $ 1,460 $ — $ — $ 1,460 Securities sold under agreement to repurchase (1) (2) (3) $ 571 $ (588 ) $ — $ (17 ) ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase. (2) U.S. Treasury and agency securities are in Fixed maturities available-for-sale on the consolidated balance sheets. (3) Cash is included in Cash and cash equivalents on consolidated balance sheets. The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018 . Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2018 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 days 30–90 days Greater Than 90 days Total (in millions) Securities sold under agreement to repurchase: (1) U.S. Treasury and agency securities $ — $ 571 $ — $ — $ 571 Total $ — $ 571 $ — $ — $ 571 ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase on the consolidated balance sheets.

CLOSED BLOCK

CLOSED BLOCK	3 Months Ended
	Mar. 31, 2019
Closed Block Disclosure [Abstract]
Closed Block	CLOSED BLOCK Summarized financial information for the Company’s Closed Block is as follows: March 31, 2019 December 31, 2018 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,670 $ 6,709 Other liabilities 70 47 Total Closed Block liabilities 6,740 6,756 Assets Designated to the Closed Block: Fixed maturities, available-for-sale, at fair value (amortized cost of $3,606 and $3,680) 3,697 3,672 Mortgage loans on real estate, net of valuation allowance of $0 and $0 1,822 1,824 Policy loans 727 736 Cash and other invested assets 142 76 Other assets 171 179 Total assets designated to the Closed Block 6,559 6,487 Excess of Closed Block liabilities over assets designated to the Closed Block 181 269 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $0 and $0 105 8 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 286 $ 277 The Company’s Closed Block revenues and expenses are as follows: Three Months Ended March 31, 2019 2018 (in millions) Revenues: Premiums and other income $ 48 $ 51 Net investment income (loss) 67 73 Investment gains (losses), net (1 ) 1 Total revenues 114 125 Benefits and Other Deductions: Policyholders’ benefits and dividends 121 126 Other operating costs and expenses 1 1 Total benefits and other deductions 122 127 Net income (loss) before income taxes (8 ) (2 ) Income tax (expense) benefit (1 ) — Net income (loss) $ (9 ) $ (2 ) A reconciliation of the Company’s policyholder dividend obligation follows: Three Months Ended March 31, 2019 2018 (in millions) Balances, beginning of year $ — $ 19 Unrealized investment gains (losses), net of DAC — (19 ) Balances, end of period $ — $ —

INSURANCE LIABILITIES

INSURANCE LIABILITIES	3 Months Ended
	Mar. 31, 2019
Insurance [Abstract]
Insurance Liabilities	INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following: • Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); • Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); • Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; • Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or • Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. Liabilities for Variable Annuity Contracts with GMDB and GMIB Features without No-Lapse Guarantee Rider (“NLG”) Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and no NLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2019 and 2018 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2019 $ 4,654 $ (107 ) $ 3,741 $ (1,991 ) Paid guarantee benefits (118 ) 4 (56 ) 21 Other changes in reserve 129 — 55 (39 ) Balance at March 31, 2019 $ 4,665 $ (103 ) $ 3,740 $ (2,009 ) Balance at January 1, 2018 $ 4,054 $ (2,030 ) $ 4,754 $ (10,488 ) Paid guarantee benefits (101 ) (54 ) (32 ) 27 Other changes in reserve 96 62 (139 ) 788 Balance at March 31, 2018 $ 4,049 $ (2,022 ) $ 4,583 $ (9,673 ) Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features liability, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7 . Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in-force with GMDB and GMIB features as of March 31, 2019 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive: Direct Variable Annuity Contracts with GMDB and GMIB Features At March 31, 2019 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,178 $ 98 $ 60 $ 181 $ 14,517 Separate Accounts 45,599 9,001 3,134 32,609 90,343 Total Account Values $ 59,777 $ 9,099 $ 3,194 $ 32,790 $ 104,860 Net amount at risk, gross $ 143 $ 143 $ 2,025 $ 18,389 $ 20,700 Net amount at risk, net of amounts reinsured $ 143 $ 138 $ 1,414 $ 18,389 $ 20,084 Average attained age of policyholders (in years) 51.4 67.1 73.8 69.2 55.3 Percentage of policyholders over age 70 10.2 % 43.5 % 66.1 % 50.7 % 19.0 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 245 $ 264 Separate Accounts — — 21,923 35,745 57,668 Total Account Values $ — $ — $ 21,942 $ 35,990 $ 57,932 Net amount at risk, gross $ — $ — $ 898 $ 8,287 $ 9,185 Net amount at risk, net of amounts reinsured $ — $ — $ 281 $ 7,515 $ 7,796 Average attained age of policyholders (in years) N/A N/A 69.0 69.0 69.0 Weighted average years remaining until annuitization N/A N/A 1.7 0.4 0.5 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance Agreements” in Note 10 of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended December 31, 2018. Separate Accounts Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total account values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related account values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds As of March 31, 2019 As of December 31, 2018 GMDB GMIB GMDB GMIB (in millions) Equity $ 39,856 $ 17,692 $ 35,541 $ 15,759 Fixed income 5,206 2,825 5,173 2,812 Balanced 44,433 36,855 41,588 33,974 Other 848 296 852 290 Total $ 90,343 $ 57,668 $ 83,154 $ 52,835 Hedging Programs for GMDB, GMIB, GIB and Other Features The Company has a program intended to hedge certain risks associated first with the GMDB feature and with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies - NLG The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the NLG feature reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below. Direct Liability Reinsurance Ceded Net (in millions) Balance at January 1, 2019 $ 787 $ (733 ) $ 54 Paid guaranteed benefits (7 ) — (7 ) Other changes in reserves 21 (11 ) 10 Balance at March 31, 2019 $ 801 $ (744 ) $ 57 Balance at January 1, 2018 $ 692 $ (664 ) $ 28 Paid guaranteed benefits (8 ) — (8 ) Other changes in reserves 18 (11 ) 7 Balance at March 31, 2018 $ 702 $ (675 ) $ 27

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value Disclosures	FAIR VALUE DISCLOSURES The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and liabilities measured at fair value on a recurring basis are summarized below. At March 31, 2019 and December 31, 2018 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at March 31, 2019 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 29,596 $ 1,169 $ 30,765 U.S. Treasury, government and agency — 12,968 — 12,968 States and political subdivisions — 424 39 463 Foreign governments — 498 — 498 Residential mortgage-backed (2) — 195 — 195 Asset-backed (3) — 71 534 605 Redeemable preferred stock 157 278 — 435 Total fixed maturities, available-for-sale 157 44,030 1,742 45,929 Other equity investments 12 — — 12 Trading account securities 296 12,408 — 12,704 Other invested assets: Short-term investments — 198 — 198 Assets of consolidated VIEs/VOEs — — 18 18 Swaps — 360 — 360 Credit default swaps — 22 — 22 Options — 2,164 — 2,164 Total other invested assets — 2,744 18 2,762 Cash equivalents 2,518 — — 2,518 GMIB reinsurance contract asset — — 2,009 2,009 Separate Accounts assets 114,780 2,750 383 117,913 Total Assets $ 117,763 $ 61,932 $ 4,152 $ 183,847 Liabilities GMxB derivative features’ liability $ — $ — $ 5,944 $ 5,944 SCS, SIO, MSO and IUL indexed features’ liability — 1,992 — 1,992 Total Liabilities $ — $ 1,992 $ 5,944 $ 7,936 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 25,202 $ 1,174 $ 26,376 U.S. Treasury, government and agency — 13,335 — 13,335 States and political subdivisions — 416 38 454 Foreign governments — 519 — 519 Residential mortgage-backed (2) — 202 — 202 Asset-backed (3) — 71 519 590 Redeemable preferred stock 163 276 — 439 Total fixed maturities, available-for-sale 163 40,021 1,731 41,915 Other equity investments 12 — — 12 Trading account securities 218 14,919 29 15,166 Other invested assets: Short-term investments — 412 — 412 Assets of consolidated VIEs/VOEs — — 19 19 Swaps — 423 — 423 Credit default swaps — 17 — 17 Options — 956 — 956 Total other invested assets — 1,808 19 1,827 Cash equivalents 2,160 — — 2,160 GMIB reinsurance contracts asset — — 1,991 1,991 Separate Accounts assets 105,159 2,733 374 108,266 Total Assets $ 107,712 $ 59,481 $ 4,144 $ 171,337 Liabilities GMxB derivative features’ liability $ — $ — $ 5,431 $ 5,431 SCS, SIO, MSO and IUL indexed features’ liability — 687 — 687 Total Liabilities $ — $ 687 $ 5,431 $ 6,118 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. Investments classified as Level 1 primarily include redeemable preferred stock, trading account securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less, and are carried at cost as a proxy for fair value measurement due to their short-term nature. Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products such as the SCS and EQUI-VEST variable annuity products, and in the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have 1, 3, 5, or 6 year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g. holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, asset-backed securities are classified as Level 3. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $148 million and $184 million at March 31, 2019 and December 31, 2018 , respectively, to recognize incremental counterparty non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, and primarily consist of corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. During the three months ended March 31, 2019 , AFS fixed maturities with fair values of $69 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $17 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.7% of total equity at March 31, 2019 . During the three months ended March 31, 2018 , AFS fixed maturities with fair values of $16 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $67 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.4% of total equity at March 31, 2018 . The tables below present reconciliations for all Level 3 assets and liabilities for the three months ended March 31, 2019 and 2018 . Level 3 Instruments - Fair Value Measurements Corporate State and Political Subdivisions Asset- backed (in millions) Balance, January 1, 2019 $ 1,174 $ 38 $ 519 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 1 — — Other comprehensive income (loss) 9 1 4 Purchases 70 — 11 Sales (33 ) — — Transfers into Level 3 (1) 17 — — Transfers out of Level 3 (1) (69 ) — — Balance, March 31, 2019 $ 1,169 $ 39 $ 534 Balance, January 1, 2018 $ 1,139 $ 40 $ 8 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 2 — — Other comprehensive income (loss) (20 ) (1 ) — Purchases 173 — — Sales (116 ) — (1 ) Transfers into Level 3 (1) 67 — — Transfers out of Level 3 (1) (16 ) — — Balance, March 31, 2018 $ 1,229 $ 39 $ 7 ______________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments (2) GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2019 $ 48 $ 1,991 $ 374 $ (5,431 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — 7 — Net derivative gains (losses), excluding non-performance risk — (13 ) — 51 Non-performance risk (1) — 40 — (460 ) Subtotal — 27 7 (409 ) Purchases (2) — 12 4 (107 ) Sales (3) — (21 ) — 3 Settlements — — (1 ) — Activity related to consolidated VIEs/VOEs (1 ) — — — Transfers out of Level 3 (4) (29 ) — (1 ) — Balance, March 31, 2019 $ 18 $ 2,009 $ 383 $ (5,944 ) Balance, January 1, 2018 $ 25 $ 10,488 $ 349 $ (4,256 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — 7 — Net derivative gains (losses), excluding non-performance risk — (854 ) — 436 Non-performance risk (1) — 13 — 49 Subtotal — (841 ) 7 485 Purchases (2) — 54 3 (93 ) Sales (3) — (27 ) (1 ) 2 Settlements — — (1 ) — Activity related to consolidated VIEs/VOEs 1 — — — Transfers into Level 3 (4) 5 — — — Balance, March 31, 2018 $ 31 $ 9,674 $ 357 $ (3,862 ) ______________ (1) The Company’s non-performance risk is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset, and the GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. The table below details changes in unrealized gains (losses) for the three months ended March 31, 2019 and 2018 by category for Level 3 assets and liabilities still held at March 31, 2019 and 2018 . Level 3 Instruments Income (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held at March 31, 2019: Change in unrealized gains (losses): Fixed maturities, available-for-sale: Corporate $ — $ — $ 9 State and political subdivisions — — 1 Asset-backed — — 4 Subtotal — — 14 GMIB reinsurance contracts — 27 — Separate Accounts assets (1) 7 — — GMxB derivative features liability — (409 ) — Total $ 7 $ (382 ) $ 14 Held at March 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale: Corporate $ — $ — $ (19 ) State and political subdivisions — — (1 ) Subtotal — — (20 ) GMIB reinsurance contracts — (842 ) — Separate Accounts assets (1) 7 — — GMxB derivative features liability — 440 — Total $ 7 $ (402 ) $ (20 ) ______________ (1) There is an investment expense that offsets this investment gain (loss). The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2019 and December 31, 2018 . Quantitative Information about Level 3 Fair Value Measurements at March 31, 2019 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 96 Matrix pricing model Spread over benchmark 15 - 580 bps 109 bps 891 Market EBITDA multiples 3.9x - 25.5x 12.7x Separate Accounts assets 359 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 2,009 Discounted cash flow Lapse rates 1.0% - 6.27% Liabilities: GMIBNLG 5,847 Discounted cash flow Non-performance risk Lapse rates Withdrawal rates Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 149 bps GWBL/GMWB 137 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (44 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 4 Discounted cash flow Lapse rates 0.5% - 11.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 93 Matrix pricing model Spread over benchmark 15 - 580 bps 104 bps 881 Market comparable companies EBITDA multiples 4.1x - 37.8x 12.1x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 1,991 Discounted cash flow Lapse rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 1.0% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 189 bps GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 1.0% - 5.7% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Excluded from the tables above at March 31, 2019 and December 31, 2018 , respectively, are approximately $796 million and $826 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities. Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at March 31, 2019 and December 31, 2018 , there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities. Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at March 31, 2019 and December 31, 2018 , there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements. Separate Accounts assets classified as Level 3 in the table at March 31, 2019 and December 31, 2018 , primarily consist of a private real estate fund and mortgage loans. A third-party appraisal valuation technique is used to measure the fair value of the private real estate investment fund, including consideration of observable replacement cost and sales comparisons for the underlying commercial properties, as well as the results from applying a discounted cash flow approach. Significant increase (decrease) in isolation in the capitalization rate and exit capitalization rate assumptions used in the discounted cash flow approach to the appraisal value would result in a higher (lower) measure of fair value. With respect to the fair value measurement of mortgage loans a discounted cash flow approach is applied, a significant increase (decrease) in the assumed spread over U.S. Treasury securities would produce a lower (higher) fair value measurement. Changes in the discount rate or factor used in the valuation techniques to determine the fair values of these private equity investments and mortgage loans generally are not correlated to changes in the other significant unobservable inputs. Significant increase (decrease) in isolation in the discount rate or factor would result in significantly lower (higher) fair value measurements. These fair value measurements are determined using substantially the same valuation techniques as earlier described above for the Company’s General Account investments in these securities. Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using the Company data. Validations of unobservable inputs are performed to the extent the Company has experience. When an input is changed the model is updated and the results of each step of the model are analyzed for reasonableness. The significant unobservable inputs used in the fair value measurement of the Company’s GMIB reinsurance contract asset are lapse rates, withdrawal rates and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates

LEASES

LEASES	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
LEASES	LEASES Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For those leases with a term greater than one year, the Company recognizes on the balance sheet at the time of lease commencement or modification a right of use (“RoU”) operating lease asset and a lease liability, initially measured at the present value of the lease payments. Lease costs are recognized in the income statement over the lease term on a straight-line basis. RoU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. The Company's lease population primarily consists of real estate leases for office space. The Company also has operating leases for various types of furniture and office equipment. For certain equipment leases, the Company applies a portfolio approach to effectively account for the operating lease RoU assets and liabilities. For certain lease agreements entered into or reassessed after the adoption of ASC 842, the Company elected to combine the lease and related non-lease components for its operating leases; however, the non-lease components associated with the Company’s operating leases are primarily variable in nature and as such are not included in the determination of the RoU asset and lease liability but are recognized in the period in which the obligation for those payments is incurred. The Company’s operating leases may include options to extend or terminate the lease, which are not included in the determination of the RoU asset or lease liability unless they are reasonably certain to be exercised. The Company's operating leases have remaining lease terms of one year to 12 years, some of which include options to extend the leases. The Company typically does not include its renewal options in its lease terms for calculating its RoU operating lease asset and lease liability as the renewal options allow the Company to maintain operational flexibility and the Company is not reasonably certain it will exercise these renewal options until close to the initial end date of the lease. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As the Company's leases do not provide an implicit rate, we used an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company primarily subleases floor space within our New Jersey and New York lease properties to various third parties. The lease term for the subleases typically corresponds to the head lease term. Balance Sheet Classification of Operating Lease Assets and Liabilities Balance Sheet Line Item March 31, 2019 (in millions) Assets Operating lease asset Other Assets $ 328 Liabilities Operating lease liability Other Liabilities $ 422 The table below summarizes the components of lease costs for the three months ended March 31, 2019 . Lease Costs Three Months Ended March 31, 2019 (in millions) Operating lease cost $ 53 Variable operating lease cost $ 3 Sublease income $ (4 ) Short-term lease expense $ 1 Maturities of lease liabilities as of March 31, 2019 are as follows: Maturities of Lease Liabilities March 31, 2019 Operating Leases (1) (in millions) 2019 $ 86 2020 89 2021 84 2022 81 2023 76 Thereafter 84 Total lease payments 500 Less: Interest (78 ) Present value of lease liabilities $ 422 ______________ (1) As of March 31, 2019 , the Company has additional operating real estate leases that have not yet commenced of approximately $10 million . These operating leases will commence in August 2019 with lease terms of five to ten years. Weighted Average of Lease Term and Discount Rate March 31, 2019 Weighted-average remaining operating lease term (years) 6 Weighted-average discount rate for operating leases 3.15 % Supplemental cash flow information related to leases was as follows: Lease Liabilities Information Three Months Ended March 31, 2019 (in millions) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21 Non-cash transactions: Leased assets obtained in exchange for new operating lease liabilities $ 1 The following table presents the Company’s future minimum lease obligation under ASC 840 as of December 31, 2018: December 31, 2018 Calendar Year (in millions) 2019 $ 81 2020 $ 74 2021 $ 69 2022 $ 67 2023 $ 63 Thereafter $ 66

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES Income tax expense for the three months ended March 31, 2019 and 2018 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.

EQUITY

EQUITY	3 Months Ended
	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Equity	EQUITY Accumulated Other Comprehensive Income (Loss) AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2019 and 2018 follow: March 31, 2019 2018 (in millions) Unrealized gains (losses) on investments $ 280 $ (129 ) Defined benefit pension plans (7 ) (5 ) Total accumulated other comprehensive income (loss) from continuing operations 273 (134 ) Less: Accumulated other comprehensive (income) loss attributable to discontinued operations, net of noncontrolling interest — (24 ) Accumulated other comprehensive income (loss) attributable to AXA Equitable $ 273 $ (158 ) The components of OCI, net of taxes for the three months ended March 31, 2019 and 2018 follow: Three Months Ended March 31, 2019 2018 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 1,243 $ (984 ) (Gains) losses reclassified to Net income (loss) during the period (1) 6 (71 ) Net unrealized gains (losses) on investments 1,249 (1,055 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (485 ) 313 Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $200 and $(197)) 764 (742 ) Change in defined benefit plans: Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost — (4 ) Change in defined benefit plans (net of deferred income tax expense (benefit) of $0 and $0) — (4 ) Total other comprehensive income (loss), net of income taxes from continuing operations 764 (746 ) Other comprehensive income (loss) from discontinued operations, net of income taxes — (10 ) Other comprehensive income (loss) attributable to AXA Equitable $ 764 $ (756 ) ______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts are presented net of income tax expense (benefit) of $1 million and $(19) million for the three months ended March 31, 2019 and 2018 , respectively. Investment gains and losses reclassified from AOCI to Net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to Net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	RELATED PARTY TRANSACTIONS The Company’s significant transactions during the three months ended March 31, 2019 with related parties are summarized below. Loans from Affiliates Senior Surplus Notes On December 28, 2018, AXA Equitable issued a $572 million senior surplus note due December 28, 2019 to Holdings, which bears interest at a fixed rate of 3.75% , payable semi-annually. The surplus note is intended to have priority in right of payments and in all other respects to any and all other surplus notes issued by AXA Equitable at any time. AXA Equitable repaid this note on March 5, 2019 and incurred $4 million of interest expense during three months ended March 31, 2019 . Investment management fees The Company recorded investment management fee expense of $24 million and $21 million , respectively, from AllianceBernstein for the three months ended March 31, 2019 and 2018.

COMMITMENT AND CONTINGENT LIABI

COMMITMENT AND CONTINGENT LIABILITIES	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of March 31, 2019 , the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $95 million . For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following AXA Equitable’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 and is pending in Connecticut Superior Court, Judicial District of Stamford. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to AXA Equitable’s COI rate increase. In early 2016, AXA Equitable raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by AXA Equitable in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek; (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal actions challenging the COI rate increase are also pending against AXA Equitable and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Two actions are also pending against AXA Equitable in New York state court. AXA Equitable is vigorously defending each of these matters. Obligation under funding agreements As a member of the FHLBNY, AXA Equitable has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require AXA Equitable to pledge qualified mortgage-backed assets and/or government securities as collateral. AXA Equitable issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. AXA Equitable issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. For other instruments used for asset liability management purposes see Note 4 . Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. Change in FHLBNY Funding Agreements during the Three Months Ended March 31, 2019 Outstanding Balance at December 31, 2018 Issued During the Period Repaid During the Period Outstanding Balance at March 31, 2019 (in millions) Short-term funding agreements: Due in one year or less $ 1,640 $ 4,470 $ 4,470 $ 1,640 Long-term funding agreements: Due in years two through five 1,569 — — 1,569 Due in more than five years 781 — — 781 Total long-term funding agreements 2,350 — — 2,350 Total funding agreements (1) $ 3,990 $ 4,470 $ 4,470 $ 3,990 ______________ (1) The $11 million and $12 million difference between the funding agreements carrying value shown in fair value table at March 31, 2019 and December 31, 2018 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements’ borrowing rates. Guarantees and Other Commitments At March 31, 2019 , the Company had $877 million of commitments under equity financing arrangements to certain limited partnerships, including $258 million of commitments to funds managed by affiliates. In addition, at March 31, 2019 , the Company had $325 million of commitments under equity financing arrangements to existing mortgage loan agreements. The Company had $19 million of undrawn letters of credit related to reinsurance at March 31, 2019 . Pursuant to certain assumption agreements (the “Assumption Agreements”), Holdings legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance and deferred compensation benefits as well as under the AXA Equitable Retirement plan, a frozen qualified pension plan. AXA Equitable remains secondarily liable for its obligations under these plans and would recognize such liabilities in the event Holdings does not perform under the terms of the Assumption Agreements.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	3 Months Ended
	Mar. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONS The results of AB are reflected in the Company’s consolidated financial statements as discontinued operations and are presented in Net income (loss) from discontinued operations, net of taxes. Intercompany transactions between the Company and AB prior to the AB Business Transfer have been eliminated. Ongoing service transactions with AB are reported as related party transactions as further described in Note 12. The table below presents AB’s revenues recognized in three months ended March 31, 2018 , disaggregated by category: Three Months Ended March 31, 2018 (in millions) Investment management and service fees: Base fees $ 568 Performance-based fees 6 Research services 114 Distribution services 108 Shareholder services 20 Other 6 Total investment management and service fees $ 822 The following table presents the amounts related to the Net income of AB that has been reflected in Discontinued Operations: Three Months Ended March 31, 2018 (in millions) REVENUES Net derivative gains (losses) $ 2 Net investment income (loss) 39 Investment management and service fees 803 Other income 2 Total revenues 846 BENEFITS AND OTHER DEDUCTIONS Compensation and benefits 344 Distribution-related payments 110 Interest expense 2 Other operating costs and expenses 189 Total benefits and other deductions 645 Income from discontinued operations, before income taxes 201 Income tax expense (17 ) Net income from discontinued operations, net of taxes 184 Less: Net income attributable to the noncontrolling interest (155 ) Net income from discontinued operations, net of taxes and noncontrolling interest $ 29

REVISION OF PRIOR PERIOD FINANC

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	3 Months Ended
	Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]
Revision of Prior Period Financial Statements	REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company changed the presentation of the capitalization of DAC in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of DAC. There was no impact on Net income (loss) or Comprehensive income (loss) from this reclassification. See Note 2 for further details of this reclassification. Revisions of Prior Period Financial Statements D uring the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. Discontinued Operations As further described in Note 13 , as a result of the AB Business Transfer in the fourth quarter of 2018, AB’s operations are now reflected as discontinued operations in the Company’s consolidated financial statements. The financial information for prior periods presented in the consolidated financial statements have been adjusted to reflect AB as discontinued operations. Revision of Consolidated Financial Statements as of and for the Three Months Ended March 31, 2018 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustment for the discontinued operations, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2018 As Previously Reported Discontinued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: DAC $ 4,826 $ — $ 4,826 $ (119 ) $ 4,707 Total Assets $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Liabilities: Future policy benefits and other policyholders’ liabilities $ 28,374 $ — $ 28,374 $ (10 ) $ 28,364 Current and deferred income taxes 1,728 (432 ) 1,296 (38 ) 1,258 Other liabilities 3,041 (1,941 ) 1,100 70 1,170 Total Liabilities $ 202,767 $ — $ 202,767 $ 22 $ 202,789 Equity: Retained earnings $ 8,824 $ — $ 8,824 $ (141 ) $ 8,683 Total equity attributable to AXA Equitable 15,545 — 15,545 (141 ) 15,404 Total Equity 18,633 — 18,633 (141 ) 18,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Three Months Ended March 31, 2018 As Previously Gross DAC Adjustment Discontinued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 869 $ — $ — $ 869 $ (8 ) $ 861 Net derivative gains (losses) (777 ) — (2 ) (779 ) (38 ) (817 ) Total revenues 2,031 — (846 ) 1,185 (46 ) 1,139 Benefits and other deductions: Policyholders’ benefits 489 — — 489 (9 ) 480 Interest credited to policyholders’ account balances 338 — — 338 (83 ) 255 Compensation and benefits 456 (33 ) (344 ) 79 70 149 Commissions 371 (101 ) (110 ) 160 — 160 Amortization of DAC 10 135 — 145 64 209 Other operating costs and expenses 440 (1 ) (189 ) 250 — 250 Total benefits and other deductions 2,115 — (645 ) 1,470 42 1,512 Income (loss) from continuing operations, before income taxes (84 ) — (201 ) (285 ) (88 ) (373 ) Income tax (expense) benefit from continuing operations 44 — 17 61 19 80 Net income (loss) from continuing operations (40 ) — (184 ) (224 ) (69 ) (293 ) Net income (loss) (40 ) — (155 ) (195 ) (69 ) (264 ) Net income (loss) attributable to AXA Equitable $ (194 ) $ — $ — $ (194 ) $ (69 ) $ (263 ) Three Months Ended March 31, 2018 As Previously Discontinued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Statement of Comprehensive Income (Loss): Net income (loss) $ (40 ) $ (155 ) $ (195 ) $ (69 ) $ (264 ) Comprehensive income (loss) $ (789 ) $ (162 ) $ (951 ) $ (69 ) $ (1,020 ) Comprehensive income (loss) attributable to AXA Equitable $ (950 ) $ (1 ) $ (951 ) $ (69 ) $ (1,020 ) Three Months Ended March 31, 2018 As Previously Discontinued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) (194 ) — (194 ) (69 ) (263 ) Retained earnings, end of period 8,824 — 8,824 (141 ) 8,683 Total AXA Equitable’s equity, end of period 15,545 — 15,545 (141 ) 15,404 Total Equity, End of Period $ 18,633 $ — $ 18,633 $ (141 ) $ 18,492 Three Months Ended March 31, 2018 As Previously Presentation Reclassifi- cations Impact of Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Cash flows from operating activities: Net income (loss) (1) $ (40 ) $ — $ (69 ) $ (109 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 338 — (83 ) 255 Policy charges and fee income (869 ) — 8 (861 ) Net derivative (gains) losses 777 — 38 815 Amortization and depreciation — 137 64 201 Amortization of deferred sales commission 7 (7 ) — — Other depreciation and amortization (23 ) 23 — — Amortization of other intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 25 (25 ) — — Changes in: Reinsurance recoverable 2 — (149 ) (147 ) DAC 10 (10 ) — — Capitalization of DAC — (135 ) — (135 ) Future policy benefits (191 ) — (7 ) (198 ) Current and deferred income taxes (52 ) — 132 80 Other, net (122 ) 64 70 12 Net cash provided by (used in) operating activities $ (21 ) $ — $ 4 $ (17 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 1,606 $ — $ 77 $ 1,683 Real estate joint ventures — 140 — 140 Short-term investments — 688 — 688 Other 54 (140 ) — (86 ) Payment for the purchase/origination of: Short-term investments — (377 ) — (377 ) Cash settlements related to derivative instruments (14 ) — (489 ) (503 ) Change in short-term investments 396 (311 ) (85 ) — Other, net (560 ) — 153 (407 ) Net cash provided by (used in) investing activities $ (639 ) $ — $ (344 ) $ (983 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,366 $ — $ (468 ) $ 1,898 Withdrawals (1,322 ) — 241 (1,081 ) Transfers (to) from Separate Accounts (115 ) — 567 452 Net cash provided by (used in) financing activities $ 1,040 $ — $ 340 $ 1,380 Non-cash transactions during the period: (Settlement) issuance of long-term debt $ — $ — $ (202 ) $ (202 ) Transfer of assets to reinsurer $ — $ — $ (604 ) $ (604 ) ______________ (1) Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss).

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS None.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Adoption of New Accounting Pronouncements and Future Adoption of New Accounting Pronouncements	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2017-12: Derivatives and Hedging (Topic 815) The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. On January 1, 2019, the Company adopted the new hedging guidance. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. Description Effect on the Financial Statement or Other Significant Matters ASU 2017-08: Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. On January 1, 2019, the Company adopted the new guidance on accounting for certain premiums on callable debt securities. As the Company’s existing accounting practices aligned with the guidance in the ASU, adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. ASU 2016-02: Leases (Topic 842) This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. On January 1, 2019, the Company adopted the new leases standard using the simplified modified retrospective transition method, as of the adoption date. Prior comparable periods will not be adjusted or presented under this method. We applied several practical expedients offered by ACS 842 upon adoption of this standard. These included continuing to account for existing leases based on judgment made under legacy U.S. GAAP as it relates to determining classification of leases, unamortized initial direct costs and whether contracts are leases or contain leases. We also used the practical expedient to use hindsight in determining lease terms (using knowledge and expectations as of the standard’s adoption date instead of the previous assumptions under legacy U.S. GAAP) and evaluated impairment of our right-of-use (“RoU”) assets in the transition period (using most up-to-date information.) Adoption of this standard resulted in the recognition, as of January 1, 2019, of additional RoU operating lease assets of $347 million reported in Other assets and operating lease liabilities of $439 million reported in Other liabilities in accompanying consolidated balance sheets. The operating RoU assets recognized as of January 1, 2019 are net of deferred rent of $58 million and liabilities associated with previously recognized impairments of $34 million. See Note 8 for additional information. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU modify disclosure requirements in Topic 820, including the removal of certain disclosure requirements, modification of certain disclosures, and the addition of new requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional requirements delayed until their effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944) This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Effective for fiscal years beginning after December 31, 2020. Early adoption is permitted. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on our consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred policy acquisition costs. The ASU simplifies the amortization of deferred policy acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, Separate Accounts liabilities and deferred policy acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments - Credit Losses (Topic 326) This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.
Accounting and Consolidation of VIEs	Accounting and Consolidation of Variable Interest Entities (“VIEs”) At March 31, 2019 , the Company held $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are $168.6 billion at March 31, 2019 . The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.1 billion and $866 million of unfunded commitments at March 31, 2019 . The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. At March 31, 2019 , the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable Life Insurance Company (“AXA Equitable Life”) and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheet at March 31, 2019 related to this VIE is $35 million of Real estate held for production of income. In addition, Real estate held for production of income reflects $16 million as related to two non-consolidated joint ventures at March 31, 2019 .
Revision of Prior Period Financial Statements	Revision of Prior Period Financial Statements D uring the second and third quarter of 2018, the Company revised its financial statements to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements as of and for the three and six months ended March 31, 2018 and June 30, 2018, respectively. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to its financial statements of any period. The impact of the misclassifications detailed in the revision tables included in Note 14 on the consolidated statement of cash flows for the three months ended March 31, 2018 were corrected in the comparative consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 contained elsewhere in the financial statements. The misclassifications for the six and nine months ended June 30, 2018 and September 30, 2018 will be corrected in the Company’s comparative consolidated statements of cash flows to be included in the Form 10-Q filings as of and for the three and six months ended June 30, 2019 and as of and for the three and nine months ended September 30, 2019, respectively. See Note 14 for further information.
Fair Value Measurements	The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles	Description Effect on the Financial Statement or Other Significant Matters ASU 2017-12: Derivatives and Hedging (Topic 815) The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. On January 1, 2019, the Company adopted the new hedging guidance. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. Description Effect on the Financial Statement or Other Significant Matters ASU 2017-08: Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. On January 1, 2019, the Company adopted the new guidance on accounting for certain premiums on callable debt securities. As the Company’s existing accounting practices aligned with the guidance in the ASU, adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. ASU 2016-02: Leases (Topic 842) This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. On January 1, 2019, the Company adopted the new leases standard using the simplified modified retrospective transition method, as of the adoption date. Prior comparable periods will not be adjusted or presented under this method. We applied several practical expedients offered by ACS 842 upon adoption of this standard. These included continuing to account for existing leases based on judgment made under legacy U.S. GAAP as it relates to determining classification of leases, unamortized initial direct costs and whether contracts are leases or contain leases. We also used the practical expedient to use hindsight in determining lease terms (using knowledge and expectations as of the standard’s adoption date instead of the previous assumptions under legacy U.S. GAAP) and evaluated impairment of our right-of-use (“RoU”) assets in the transition period (using most up-to-date information.) Adoption of this standard resulted in the recognition, as of January 1, 2019, of additional RoU operating lease assets of $347 million reported in Other assets and operating lease liabilities of $439 million reported in Other liabilities in accompanying consolidated balance sheets. The operating RoU assets recognized as of January 1, 2019 are net of deferred rent of $58 million and liabilities associated with previously recognized impairments of $34 million. See Note 8 for additional information. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU modify disclosure requirements in Topic 820, including the removal of certain disclosure requirements, modification of certain disclosures, and the addition of new requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional requirements delayed until their effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944) This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Effective for fiscal years beginning after December 31, 2020. Early adoption is permitted. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on our consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred policy acquisition costs. The ASU simplifies the amortization of deferred policy acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, Separate Accounts liabilities and deferred policy acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments - Credit Losses (Topic 326) This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. The reclassification adjustments for the three months ended March 31, 2018 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item. Three Months Ended March 31, 2018 (in millions) Reductions to expense line items: Compensation and benefits $ 33 Commissions 101 Other operating costs and expenses 1 Total reductions $ 135 Increase to expense line item: Amortization of deferred policy acquisition costs $ 135
Revenues Disaggregated by Category	The table below presents the revenues recognized during the three months ended March 31, 2019 and 2018 , disaggregated by category: Three Months Ended March 31, 2019 2018 (in millions) Investment management and service fees: Base fees $ 178 $ 182 Distribution services 70 72 Total investment management and service fees $ 248 $ 254 Other income $ 5 $ 7

INVESTMENTS (Tables)

INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities by Classification	The following tables provide information relating to fixed maturities classified as available-for-sale (“AFS”). Available-for-Sale Securities by Classification Amortized Gross Unrealized Gross Unrealized Fair OTTI (in millions) March 31, 2019: Fixed Maturities: Corporate (1) $ 30,106 $ 867 $ 208 $ 30,765 $ — U.S. Treasury, government and agency 12,719 462 213 12,968 — States and political subdivisions 408 55 — 463 — Foreign governments 478 27 7 498 — Residential mortgage-backed (2) 185 10 — 195 — Asset-backed (3) 608 1 4 605 2 Redeemable preferred stock 422 16 3 435 — Total at March 31, 2019 $ 44,926 $ 1,438 $ 435 $ 45,929 $ 2 December 31, 2018: Fixed Maturities: Corporate (1) $ 26,690 $ 385 $ 699 $ 26,376 $ — U.S. Treasury, government and agency 13,646 143 454 13,335 — States and political subdivisions 408 47 1 454 — Foreign governments 515 17 13 519 — Residential mortgage-backed (2) 193 9 — 202 — Asset-backed (3) 600 1 11 590 2 Redeemable preferred stock 440 16 17 439 — Total at December 31, 2018 $ 42,492 $ 618 $ 1,195 $ 41,915 $ 2 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in Net income (loss).
Available-for-sale Securities Fixed Maturities Contractual Maturities	The contractual maturities of AFS fixed maturities at March 31, 2019 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) March 31, 2019: Due in one year or less $ 1,817 $ 1,829 Due in years two through five 10,322 10,519 Due in years six through ten 14,953 15,367 Due after ten years 16,619 16,979 Subtotal 43,711 44,694 Residential mortgage-backed 185 195 Asset-backed 608 605 Redeemable preferred stock 422 435 Total at March 31, 2019 $ 44,926 $ 45,929
Proceeds from Sales, Gross Gains (Losses) and OTTI for AFS Fixed Maturities	The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the three months ended March 31, 2019 and 2018 : Three Months Ended March 31, 2019 2018 (in millions) Proceeds from sales $ 1,361 $ 3,428 Gross gains on sales $ 8 $ 127 Gross losses on sales $ (15 ) $ (41 ) Total OTTI $ — $ — Non-credit losses recognized in OCI — — Credit losses recognized in Net income (loss) $ — $ —
Fixed Maturities - Credit Loss Impairments	The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments Three Months Ended March 31, 2019 2018 (in millions) Balances at January 1, $ (46 ) $ (10 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 28 — Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired — — Additional impairments this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at March 31, $ (18 ) $ (10 ) ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
Net Unrealized Gain (Loss) on Fixed Maturities and Equity Securities Included in AOCI	Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: Net Unrealized Gains (Losses) on Fixed Maturities Classified as AFS March 31, 2019 December 31, 2018 (in millions) Fixed maturities available-for-sale: With OTTI loss $ — $ — All other 1,003 (577 ) Net unrealized gains (losses) $ 1,003 $ (577 )
Net Unrealized Gain (Losses) on Fixed Maturities with OTTI Losses	The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net DAC Policyholders’ Deferred AOCI Gain (in millions) Balances at January 1, 2019 $ — $ — $ — $ — $ — Net investment gains (losses) arising during the period (10 ) — — — (10 ) Reclassification adjustment: Included in Net income (loss) 10 — — — 10 Impact of net unrealized investment gains (losses) on: DAC — — — — — Deferred income taxes — — — — — Policyholders’ liabilities — — — — — Balances at March 31, 2019 $ — $ — $ — $ — $ — Balances at January 1, 2018 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) Net investment gains (losses) arising during the period — — — — — Reclassification adjustment: Included in Net income (loss) (2 ) — — — (2 ) Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — — — Policyholders’ liabilities — — 1 — 1 Balances at March 31, 2018 $ (1 ) $ — $ — $ (5 ) $ (6 )
All Other Net Unrealized Investment Gains (Losses) in AOCI	All Other Net Unrealized Investment Gains (Losses) in AOCI Net DAC Policyholders’ Deferred AOCI Gain (in millions) Balances at January 1, 2019 $ (577 ) $ 39 $ (55 ) $ 125 $ (468 ) Net investment gains (losses) arising during the period 1,583 — — — 1,583 Reclassification adjustment: — Included in Net income (loss) (3 ) — — — (3 ) Impact of net unrealized investment gains (losses) on: DAC — (655 ) — — (655 ) Deferred income taxes — — — (211 ) (211 ) Policyholders’ liabilities — — 77 — 77 Balances at March 31, 2019 $ 1,003 $ (616 ) $ 22 $ (86 ) $ 323 Balances at January 1, 2018 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 Net investment gains (losses) arising during the period (1,245 ) — — — (1,245 ) Reclassification adjustment: Included in Net income (loss) (88 ) — — — (88 ) Impact of net unrealized investment gains (losses) on: DAC — 288 — — 288 Deferred income taxes — — — 197 197 Policyholders’ liabilities — — 108 — 108 Balances at March 31, 2018 $ 193 $ (27 ) $ (124 ) $ (103 ) $ (61 )
Schedule of Gross Unrealized Loss on Investments	The following tables disclose the fair values and gross unrealized losses of the 674 issues at March 31, 2019 and the 1,471 issues at December 31, 2018 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) March 31, 2019: Fixed Maturities: Corporate $ 653 $ 6 $ 5,387 $ 202 $ 6,040 $ 208 U.S. Treasury, government and agency — — 3,163 213 3,163 213 Foreign governments — — 67 7 67 7 Asset-backed 279 1 249 3 528 4 Redeemable preferred stock 44 1 35 2 79 3 Total at March 31, 2019 $ 976 $ 8 $ 8,901 $ 427 $ 9,877 $ 435 December 31, 2018: Fixed Maturities: Corporate $ 8,369 $ 306 $ 6,161 $ 393 $ 14,530 $ 699 U.S. Treasury, government and agency 2,636 68 3,154 386 5,790 454 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 13 — 13 — Asset-backed 558 11 6 — 564 11 Redeemable preferred stock 160 12 31 5 191 17 Total at December 31, 2018 $ 11,832 $ 400 $ 9,460 $ 795 $ 21,292 $ 1,195
Net Investment Income (Loss) from Trading Securities	The table below shows a breakdown of Net investment income (loss) from trading account securities during the three months ended March 31, 2019 and 2018 : Net Investment Income (Loss) from Trading Account Securities Three Months Ended March 31, 2019 2018 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ 274 $ (96 ) Net investment gains (losses) recognized on securities sold during the period (24 ) (1 ) Net investment gains (losses) on trading account securities arising during the period 250 (97 ) Interest and dividend income from trading account securities 90 66 Net investment income (loss) from trading account securities $ 340 $ (31 )
Valuation Allowance for Mortgage Loans	The change in the valuation allowance for credit losses for commercial mortgage loans during the three months ended March 31, 2019 and 2018 are as follows: Three Months Ended March 31, 2019 2018 (in millions) Allowance for credit losses: Beginning balance, January 1, $ 7 $ 8 Charge-offs (7 ) — Recoveries — (1 ) Provision — — Ending balance, March 31, $ — $ 7 March 31, Individually Evaluated for Impairment $ — $ 7
Mortgage Loans by Loan-To-Value and Debt Service Coverage Ratios	The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at March 31, 2019 and December 31, 2018 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Total Mortgage Loans Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x (in millions) March 31, 2019: Commercial Mortgage Loans 0% - 50% $ 764 $ 21 $ 215 $ 24 $ — $ — $ 1,024 50% - 70% 4,933 806 1,284 474 — — 7,497 70% - 90% 266 — 117 334 132 — 849 90% plus — — — — — — — Total Commercial Mortgage Loans $ 5,963 $ 827 $ 1,616 $ 832 $ 132 $ — $ 9,370 Agricultural Mortgage Loans 0% - 50% $ 278 $ 130 $ 276 $ 563 $ 350 $ 49 $ 1,646 50% - 70% 119 70 248 357 237 34 1,065 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 397 $ 200 $ 524 $ 939 $ 587 $ 83 $ 2,730 Total Mortgage Loans 0% - 50% $ 1,042 $ 151 $ 491 $ 587 $ 350 $ 49 $ 2,670 50% - 70% 5,052 876 1,532 831 237 34 8,562 70% - 90% 266 — 117 353 132 — 868 90% plus — — — — — — — Total Mortgage Loans $ 6,360 $ 1,027 $ 2,140 $ 1,771 $ 719 $ 83 $ 12,100 December 31, 2018: Commercial Mortgage Loans 0% - 50% $ 780 $ 21 $ 247 $ 24 $ — $ — $ 1,072 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,948 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,130 Agricultural Mortgage Loans 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans 0% - 50% $ 1,062 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,683 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,342 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,825 ______________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
Age Analysis of Past Due Mortgage Loans	The following table provides information relating to the aging analysis of past due mortgage loans at March 31, 2019 and December 31, 2018 . Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) March 31, 2019 Commercial $ — $ — $ — $ — $ 9,370 $ 9,370 $ — Agricultural 9 26 55 90 2,640 2,730 54 Total Mortgage Loans $ 9 $ 26 $ 55 $ 90 $ 12,010 $ 12,100 $ 54 December 31, 2018 Commercial $ — $ — $ 27 $ 27 $ 9,103 $ 9,130 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,730 $ 11,825 $ 40
Impaired Mortgage Loans	The following table provides information relating to impaired mortgage loans at March 31, 2019 and December 31, 2018 . Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) March 31, 2019: With no related allowance recorded: Agricultural mortgage loans $ 2 $ 2 $ — $ 2 $ — Total $ 2 $ 2 $ — $ 2 $ — With related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ 13 $ — Total $ — $ — $ — $ 13 $ — December 31, 2018: With no related allowance recorded: Agricultural mortgage loans $ 2 $ 2 $ — $ — $ — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Total $ 27 $ 31 $ (7 ) $ 27 $ — ______________ (1) Represents a two-quarter and five-quarter average of recorded amortized cost at March 31, 2019 and December 31, 2018 , respectively.

DERIVATIVES (Tables)

DERIVATIVES (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments by Category	The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At March 31, 2019 Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2019 Fair Value Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (2): Equity contracts: Futures $ 6,544 $ — $ — $ (738 ) Swaps 8,065 6 371 (973 ) Options 37,417 3,474 1,310 1,101 Interest rate contracts: Swaps 28,153 910 209 648 Futures 16,385 — — 55 Credit contracts: Credit default swaps 1,242 22 — 10 Other freestanding contracts: Foreign currency contracts 1,796 24 1 10 Margin — 16 — — Collateral — 9 2,556 — Embedded Derivatives (2): GMIB reinsurance contracts — 2,009 — 27 GMxB derivative features liability (3) — — 5,944 (409 ) SCS, SIO, MSO and IUL indexed features (4) — — 1,992 (1,286 ) Total $ 99,602 $ 6,470 $ 12,383 $ (1,555 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. At December 31, 2018 Gains (Losses) Reported in Net Income (Loss) Three Months Ended March 31, 2018 Fair Value Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (2): Equity contracts: Futures $ 10,411 $ — $ — $ (29 ) Swaps 7,697 140 168 64 Options 21,698 2,119 1,163 (15 ) Interest rate contracts: Swaps 27,003 632 194 (490 ) Futures 11,448 — — 40 Credit contracts: Credit default swaps 1,282 17 — — Other freestanding contracts: Foreign currency contracts 2,097 27 14 (51 ) Margin — 7 5 — Collateral — 3 1,564 — Embedded Derivatives (2): GMIB reinsurance contracts — 1,991 — (842 ) GMxB derivative features liability (3) — — 5,431 485 SCS, SIO, MSO and IUL indexed features (4) — — 687 21 Total $ 81,636 $ 4,936 $ 9,226 $ (817 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets.
Offsetting Financial Assets and Liabilities and Derivative Instruments	The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2018 . Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total derivatives $ 2,946 $ 2,912 $ 34 Other financial instruments 1,520 — 1,520 Other invested assets $ 4,466 $ 2,912 $ 1,554 Liabilities Total derivatives $ 3,109 $ 2,912 $ 197 Other financial liabilities 1,263 — 1,263 Other liabilities $ 4,372 $ 2,912 $ 1,460 Securities sold under agreement to repurchase (1) $ 571 $ — $ 571 ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase. The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2019 . Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total derivatives $ 4,460 $ 4,399 $ 61 Other financial instruments 1,688 — 1,688 Other invested assets $ 6,148 $ 4,399 $ 1,749 Liabilities Total derivatives $ 4,399 $ 4,352 $ 47 Other financial liabilities 1,553 — 1,553 Other liabilities $ 5,952 $ 4,352 $ 1,600
Gross Collateral Amounts Not Offset in Consolidated Balance Sheets	The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at March 31, 2019 . Collateral Amounts Not Offset in the Consolidated Balance Sheets At March 31, 2019 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash Net Amount (in millions) Assets Total derivatives $ 2,546 $ 367 $ 2,118 $ 61 Other financial instruments 1,688 — — 1,688 Other invested assets $ 4,234 $ 367 $ 2,118 $ 1,749 Liabilities Total derivatives $ 47 $ — $ — $ 47 Other financial liabilities 1,553 — — 1,553 Other liabilities $ 1,600 $ — $ — $ 1,600 The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018 . Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash Net Amount (in millions) Assets Total derivatives $ 1,397 $ — $ (1,363 ) $ 34 Other financial instruments 1,520 — — 1,520 Other invested assets $ 2,917 $ — $ (1,363 ) $ 1,554 Liabilities Total derivatives $ 197 $ — $ — $ 197 Other financial liabilities 1,263 — — 1,263 Other liabilities $ 1,460 $ — $ — $ 1,460 Securities sold under agreement to repurchase (1) (2) (3) $ 571 $ (588 ) $ — $ (17 ) ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase. (2) U.S. Treasury and agency securities are in Fixed maturities available-for-sale on the consolidated balance sheets. (3) Cash is included in Cash and cash equivalents on consolidated balance sheets.
Repurchase Agreements Accounted for as Secured Borrowings	The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018 . Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2018 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 days 30–90 days Greater Than 90 days Total (in millions) Securities sold under agreement to repurchase: (1) U.S. Treasury and agency securities $ — $ 571 $ — $ — $ 571 Total $ — $ 571 $ — $ — $ 571 ______________ (1) Excludes expense of $2 million in Securities sold under agreement to repurchase on the consolidated balance sheets.

CLOSED BLOCK (Tables)

CLOSED BLOCK (Tables)	3 Months Ended
	Mar. 31, 2019
Closed Block Disclosure [Abstract]
Summarized Financial Information for Closed Blocks	Summarized financial information for the Company’s Closed Block is as follows: March 31, 2019 December 31, 2018 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,670 $ 6,709 Other liabilities 70 47 Total Closed Block liabilities 6,740 6,756 Assets Designated to the Closed Block: Fixed maturities, available-for-sale, at fair value (amortized cost of $3,606 and $3,680) 3,697 3,672 Mortgage loans on real estate, net of valuation allowance of $0 and $0 1,822 1,824 Policy loans 727 736 Cash and other invested assets 142 76 Other assets 171 179 Total assets designated to the Closed Block 6,559 6,487 Excess of Closed Block liabilities over assets designated to the Closed Block 181 269 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $0 and $0 105 8 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 286 $ 277
Closed Block Revenues and Expenses	The Company’s Closed Block revenues and expenses are as follows: Three Months Ended March 31, 2019 2018 (in millions) Revenues: Premiums and other income $ 48 $ 51 Net investment income (loss) 67 73 Investment gains (losses), net (1 ) 1 Total revenues 114 125 Benefits and Other Deductions: Policyholders’ benefits and dividends 121 126 Other operating costs and expenses 1 1 Total benefits and other deductions 122 127 Net income (loss) before income taxes (8 ) (2 ) Income tax (expense) benefit (1 ) — Net income (loss) $ (9 ) $ (2 )
Reconciliation of Policy Holder Dividend Obligation	A reconciliation of the Company’s policyholder dividend obligation follows: Three Months Ended March 31, 2019 2018 (in millions) Balances, beginning of year $ — $ 19 Unrealized investment gains (losses), net of DAC — (19 ) Balances, end of period $ — $ —

INSURANCE LIABILITIES (Tables)

INSURANCE LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2019
Insurance [Abstract]
GMDB and GMIB Liabilities and Other Policyholder's Liabilities	Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2019 and 2018 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2019 $ 4,654 $ (107 ) $ 3,741 $ (1,991 ) Paid guarantee benefits (118 ) 4 (56 ) 21 Other changes in reserve 129 — 55 (39 ) Balance at March 31, 2019 $ 4,665 $ (103 ) $ 3,740 $ (2,009 ) Balance at January 1, 2018 $ 4,054 $ (2,030 ) $ 4,754 $ (10,488 ) Paid guarantee benefits (101 ) (54 ) (32 ) 27 Other changes in reserve 96 62 (139 ) 788 Balance at March 31, 2018 $ 4,049 $ (2,022 ) $ 4,583 $ (9,673 )
Variable Annuity Contracts with GMDB and GMIB Features	Direct Variable Annuity Contracts with GMDB and GMIB Features At March 31, 2019 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,178 $ 98 $ 60 $ 181 $ 14,517 Separate Accounts 45,599 9,001 3,134 32,609 90,343 Total Account Values $ 59,777 $ 9,099 $ 3,194 $ 32,790 $ 104,860 Net amount at risk, gross $ 143 $ 143 $ 2,025 $ 18,389 $ 20,700 Net amount at risk, net of amounts reinsured $ 143 $ 138 $ 1,414 $ 18,389 $ 20,084 Average attained age of policyholders (in years) 51.4 67.1 73.8 69.2 55.3 Percentage of policyholders over age 70 10.2 % 43.5 % 66.1 % 50.7 % 19.0 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 245 $ 264 Separate Accounts — — 21,923 35,745 57,668 Total Account Values $ — $ — $ 21,942 $ 35,990 $ 57,932 Net amount at risk, gross $ — $ — $ 898 $ 8,287 $ 9,185 Net amount at risk, net of amounts reinsured $ — $ — $ 281 $ 7,515 $ 7,796 Average attained age of policyholders (in years) N/A N/A 69.0 69.0 69.0 Weighted average years remaining until annuitization N/A N/A 1.7 0.4 0.5 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5%
Investment in Variable Insurance Trust Mutual Funds	The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related account values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds As of March 31, 2019 As of December 31, 2018 GMDB GMIB GMDB GMIB (in millions) Equity $ 39,856 $ 17,692 $ 35,541 $ 15,759 Fixed income 5,206 2,825 5,173 2,812 Balanced 44,433 36,855 41,588 33,974 Other 848 296 852 290 Total $ 90,343 $ 57,668 $ 83,154 $ 52,835
Summary of No-Lapse Guarantee Liabilities and Other Policyholder's Liabilities	The change in the NLG feature reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below. Direct Liability Reinsurance Ceded Net (in millions) Balance at January 1, 2019 $ 787 $ (733 ) $ 54 Paid guaranteed benefits (7 ) — (7 ) Other changes in reserves 21 (11 ) 10 Balance at March 31, 2019 $ 801 $ (744 ) $ 57 Balance at January 1, 2018 $ 692 $ (664 ) $ 28 Paid guaranteed benefits (8 ) — (8 ) Other changes in reserves 18 (11 ) 7 Balance at March 31, 2018 $ 702 $ (675 ) $ 27

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are summarized below. At March 31, 2019 and December 31, 2018 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at March 31, 2019 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 29,596 $ 1,169 $ 30,765 U.S. Treasury, government and agency — 12,968 — 12,968 States and political subdivisions — 424 39 463 Foreign governments — 498 — 498 Residential mortgage-backed (2) — 195 — 195 Asset-backed (3) — 71 534 605 Redeemable preferred stock 157 278 — 435 Total fixed maturities, available-for-sale 157 44,030 1,742 45,929 Other equity investments 12 — — 12 Trading account securities 296 12,408 — 12,704 Other invested assets: Short-term investments — 198 — 198 Assets of consolidated VIEs/VOEs — — 18 18 Swaps — 360 — 360 Credit default swaps — 22 — 22 Options — 2,164 — 2,164 Total other invested assets — 2,744 18 2,762 Cash equivalents 2,518 — — 2,518 GMIB reinsurance contract asset — — 2,009 2,009 Separate Accounts assets 114,780 2,750 383 117,913 Total Assets $ 117,763 $ 61,932 $ 4,152 $ 183,847 Liabilities GMxB derivative features’ liability $ — $ — $ 5,944 $ 5,944 SCS, SIO, MSO and IUL indexed features’ liability — 1,992 — 1,992 Total Liabilities $ — $ 1,992 $ 5,944 $ 7,936 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 25,202 $ 1,174 $ 26,376 U.S. Treasury, government and agency — 13,335 — 13,335 States and political subdivisions — 416 38 454 Foreign governments — 519 — 519 Residential mortgage-backed (2) — 202 — 202 Asset-backed (3) — 71 519 590 Redeemable preferred stock 163 276 — 439 Total fixed maturities, available-for-sale 163 40,021 1,731 41,915 Other equity investments 12 — — 12 Trading account securities 218 14,919 29 15,166 Other invested assets: Short-term investments — 412 — 412 Assets of consolidated VIEs/VOEs — — 19 19 Swaps — 423 — 423 Credit default swaps — 17 — 17 Options — 956 — 956 Total other invested assets — 1,808 19 1,827 Cash equivalents 2,160 — — 2,160 GMIB reinsurance contracts asset — — 1,991 1,991 Separate Accounts assets 105,159 2,733 374 108,266 Total Assets $ 107,712 $ 59,481 $ 4,144 $ 171,337 Liabilities GMxB derivative features’ liability $ — $ — $ 5,431 $ 5,431 SCS, SIO, MSO and IUL indexed features’ liability — 687 — 687 Total Liabilities $ — $ 687 $ 5,431 $ 6,118 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The tables below present reconciliations for all Level 3 assets and liabilities for the three months ended March 31, 2019 and 2018 . Level 3 Instruments - Fair Value Measurements Corporate State and Political Subdivisions Asset- backed (in millions) Balance, January 1, 2019 $ 1,174 $ 38 $ 519 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 1 — — Other comprehensive income (loss) 9 1 4 Purchases 70 — 11 Sales (33 ) — — Transfers into Level 3 (1) 17 — — Transfers out of Level 3 (1) (69 ) — — Balance, March 31, 2019 $ 1,169 $ 39 $ 534 Balance, January 1, 2018 $ 1,139 $ 40 $ 8 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 2 — — Other comprehensive income (loss) (20 ) (1 ) — Purchases 173 — — Sales (116 ) — (1 ) Transfers into Level 3 (1) 67 — — Transfers out of Level 3 (1) (16 ) — — Balance, March 31, 2018 $ 1,229 $ 39 $ 7 ______________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments (2) GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2019 $ 48 $ 1,991 $ 374 $ (5,431 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — 7 — Net derivative gains (losses), excluding non-performance risk — (13 ) — 51 Non-performance risk (1) — 40 — (460 ) Subtotal — 27 7 (409 ) Purchases (2) — 12 4 (107 ) Sales (3) — (21 ) — 3 Settlements — — (1 ) — Activity related to consolidated VIEs/VOEs (1 ) — — — Transfers out of Level 3 (4) (29 ) — (1 ) — Balance, March 31, 2019 $ 18 $ 2,009 $ 383 $ (5,944 ) Balance, January 1, 2018 $ 25 $ 10,488 $ 349 $ (4,256 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — 7 — Net derivative gains (losses), excluding non-performance risk — (854 ) — 436 Non-performance risk (1) — 13 — 49 Subtotal — (841 ) 7 485 Purchases (2) — 54 3 (93 ) Sales (3) — (27 ) (1 ) 2 Settlements — — (1 ) — Activity related to consolidated VIEs/VOEs 1 — — — Transfers into Level 3 (4) 5 — — — Balance, March 31, 2018 $ 31 $ 9,674 $ 357 $ (3,862 ) ______________ (1) The Company’s non-performance risk is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset, and the GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.
Fair Value Assets Unrealized Gains Losses By Category For Level 3 Assets And Liabilities Still Held	The table below details changes in unrealized gains (losses) for the three months ended March 31, 2019 and 2018 by category for Level 3 assets and liabilities still held at March 31, 2019 and 2018 . Level 3 Instruments Income (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held at March 31, 2019: Change in unrealized gains (losses): Fixed maturities, available-for-sale: Corporate $ — $ — $ 9 State and political subdivisions — — 1 Asset-backed — — 4 Subtotal — — 14 GMIB reinsurance contracts — 27 — Separate Accounts assets (1) 7 — — GMxB derivative features liability — (409 ) — Total $ 7 $ (382 ) $ 14 Held at March 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale: Corporate $ — $ — $ (19 ) State and political subdivisions — — (1 ) Subtotal — — (20 ) GMIB reinsurance contracts — (842 ) — Separate Accounts assets (1) 7 — — GMxB derivative features liability — 440 — Total $ 7 $ (402 ) $ (20 ) ______________ (1) There is an investment expense that offsets this investment gain (loss).
Fair Value Inputs Quantitative Information	The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2019 and December 31, 2018 . Quantitative Information about Level 3 Fair Value Measurements at March 31, 2019 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 96 Matrix pricing model Spread over benchmark 15 - 580 bps 109 bps 891 Market EBITDA multiples 3.9x - 25.5x 12.7x Separate Accounts assets 359 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 2,009 Discounted cash flow Lapse rates 1.0% - 6.27% Liabilities: GMIBNLG 5,847 Discounted cash flow Non-performance risk Lapse rates Withdrawal rates Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 149 bps GWBL/GMWB 137 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (44 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 4 Discounted cash flow Lapse rates 0.5% - 11.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 93 Matrix pricing model Spread over benchmark 15 - 580 bps 104 bps 881 Market comparable companies EBITDA multiples 4.1x - 37.8x 12.1x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 1,991 Discounted cash flow Lapse rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 1.0% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk Annuitization rates Mortality rates (1): Ages 0 - 40 Ages 41 - 60 Ages 60 - 115 189 bps GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 1.0% - 5.7% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
Fair Value Disclosure Financial Instruments Not Carried At Fair Value	The carrying values and fair values at March 31, 2019 and December 31, 2018 for financial instruments not otherwise disclosed in Notes 3 and 4 are presented in the table below. Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) March 31, 2019: Mortgage loans on real estate $ 12,100 $ — $ — $ 12,002 $ 12,002 FHLBNY Funding Agreements $ 4,001 $ — $ 4,011 $ — $ 4,011 Policy loans $ 3,253 $ — $ — $ 4,064 $ 4,064 Loans to affiliates $ 600 $ — $ 610 $ — $ 610 Policyholders’ liabilities: Investment contracts $ 1,983 $ — $ — $ 2,094 $ 2,094 Separate Accounts liabilities $ 8,173 $ — $ — $ 8,173 $ 8,173 December 31, 2018: Mortgage loans on real estate $ 11,818 $ — $ — $ 11,478 $ 11,478 FHLBNY Funding Agreements $ 4,002 $ — $ 3,956 $ — $ 3,956 Policy loans $ 3,267 $ — $ — $ 3,944 $ 3,944 Loans to affiliates $ 600 $ — $ 603 $ — $ 603 Policyholders’ liabilities: Investment contracts $ 1,974 $ — $ — $ 2,015 $ 2,015 Loans from affiliates $ 572 $ — $ 572 $ — $ 572 Separate Accounts liabilities $ 7,406 $ — $ — $ 7,406 $ 7,406

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Assets and Liabilities, Leases	Balance Sheet Classification of Operating Lease Assets and Liabilities Balance Sheet Line Item March 31, 2019 (in millions) Assets Operating lease asset Other Assets $ 328 Liabilities Operating lease liability Other Liabilities $ 422
Lease, Cost	The table below summarizes the components of lease costs for the three months ended March 31, 2019 . Lease Costs Three Months Ended March 31, 2019 (in millions) Operating lease cost $ 53 Variable operating lease cost $ 3 Sublease income $ (4 ) Short-term lease expense $ 1 Weighted Average of Lease Term and Discount Rate March 31, 2019 Weighted-average remaining operating lease term (years) 6 Weighted-average discount rate for operating leases 3.15 % Supplemental cash flow information related to leases was as follows: Lease Liabilities Information Three Months Ended March 31, 2019 (in millions) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21 Non-cash transactions: Leased assets obtained in exchange for new operating lease liabilities $ 1
Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities as of March 31, 2019 are as follows: Maturities of Lease Liabilities March 31, 2019 Operating Leases (1) (in millions) 2019 $ 86 2020 89 2021 84 2022 81 2023 76 Thereafter 84 Total lease payments 500 Less: Interest (78 ) Present value of lease liabilities $ 422 ______________ (1) As of March 31, 2019 , the Company has additional operating real estate leases that have not yet commenced of approximately $10 million . These operating leases will commence in August 2019 with lease terms of five to ten years.
Schedule of Future Minimum Rental Payments for Operating Leases	The following table presents the Company’s future minimum lease obligation under ASC 840 as of December 31, 2018: December 31, 2018 Calendar Year (in millions) 2019 $ 81 2020 $ 74 2021 $ 69 2022 $ 67 2023 $ 63 Thereafter $ 66

EQUITY (Tables)

EQUITY (Tables)	3 Months Ended
	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2019 and 2018 follow: March 31, 2019 2018 (in millions) Unrealized gains (losses) on investments $ 280 $ (129 ) Defined benefit pension plans (7 ) (5 ) Total accumulated other comprehensive income (loss) from continuing operations 273 (134 ) Less: Accumulated other comprehensive (income) loss attributable to discontinued operations, net of noncontrolling interest — (24 ) Accumulated other comprehensive income (loss) attributable to AXA Equitable $ 273 $ (158 )
Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes	The components of OCI, net of taxes for the three months ended March 31, 2019 and 2018 follow: Three Months Ended March 31, 2019 2018 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 1,243 $ (984 ) (Gains) losses reclassified to Net income (loss) during the period (1) 6 (71 ) Net unrealized gains (losses) on investments 1,249 (1,055 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (485 ) 313 Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $200 and $(197)) 764 (742 ) Change in defined benefit plans: Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost — (4 ) Change in defined benefit plans (net of deferred income tax expense (benefit) of $0 and $0) — (4 ) Total other comprehensive income (loss), net of income taxes from continuing operations 764 (746 ) Other comprehensive income (loss) from discontinued operations, net of income taxes — (10 ) Other comprehensive income (loss) attributable to AXA Equitable $ 764 $ (756 ) ______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts are presented net of income tax expense (benefit) of $1 million and $(19) million for the three months ended March 31, 2019 and 2018 , respectively.

COMMITMENT AND CONTINGENT LIA_2

COMMITMENT AND CONTINGENT LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Federal Home Loan Bank, Advances	Outstanding Balance at December 31, 2018 Issued During the Period Repaid During the Period Outstanding Balance at March 31, 2019 (in millions) Short-term funding agreements: Due in one year or less $ 1,640 $ 4,470 $ 4,470 $ 1,640 Long-term funding agreements: Due in years two through five 1,569 — — 1,569 Due in more than five years 781 — — 781 Total long-term funding agreements 2,350 — — 2,350 Total funding agreements (1) $ 3,990 $ 4,470 $ 4,470 $ 3,990 ______________ (1) The $11 million and $12 million difference between the funding agreements carrying value shown in fair value table at March 31, 2019 and December 31, 2018 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements’ borrowing rates.

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	3 Months Ended
	Mar. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The table below presents AB’s revenues recognized in three months ended March 31, 2018 , disaggregated by category: Three Months Ended March 31, 2018 (in millions) Investment management and service fees: Base fees $ 568 Performance-based fees 6 Research services 114 Distribution services 108 Shareholder services 20 Other 6 Total investment management and service fees $ 822 The following table presents the amounts related to the Net income of AB that has been reflected in Discontinued Operations: Three Months Ended March 31, 2018 (in millions) REVENUES Net derivative gains (losses) $ 2 Net investment income (loss) 39 Investment management and service fees 803 Other income 2 Total revenues 846 BENEFITS AND OTHER DEDUCTIONS Compensation and benefits 344 Distribution-related payments 110 Interest expense 2 Other operating costs and expenses 189 Total benefits and other deductions 645 Income from discontinued operations, before income taxes 201 Income tax expense (17 ) Net income from discontinued operations, net of taxes 184 Less: Net income attributable to the noncontrolling interest (155 ) Net income from discontinued operations, net of taxes and noncontrolling interest $ 29

REVISION OF PRIOR PERIOD FINA_2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	3 Months Ended
	Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]
Financial Information Affected by Revisions and Change in Accounting Principle	.

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
AXA Equity Holdings [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Ownership percentage	48.00%	59.00%

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - Impact of New Accounting Pronouncements (Details) - USD ($) $ in Millions	Jan. 01, 2019	Mar. 31, 2019	Mar. 31, 2018
Accounting Policies [Abstract]
Operating lease asset	$ 347	$ 328
Operating lease liability	439	422
Amortization of deferred policy acquisition costs		$ 165	$ 209
Deferred Rent Credit	58
Operating Lease, Impairment Loss	$ 34

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Variable Interest Entity [Line Items]
Amortization of deferred policy acquisition costs	$ 165	$ 209
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Variable Interest Entity, nonconsolidated net assets	168,600
Variable interest, maximum loss exposure	1,100
Variable interest entity, unused commitments	866
Variable interest entity, consolidated, assets	1,100
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Variable interest entity, consolidated, assets	35
Operating income (loss)	$ 16

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Reclassification of DAC (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization of deferred policy acquisition costs	$ 165	$ 209
Reclassification Of DAC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		135
Amortization of deferred policy acquisition costs		135
Reclassification Of DAC | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		33
Reclassification Of DAC | Commissions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		101
Reclassification Of DAC | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		$ 1

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Total investment management and service fees
Disaggregation of Revenue [Line Items]
Revenues disaggregated by category	$ 248	$ 254
Base fees
Disaggregation of Revenue [Line Items]
Revenues disaggregated by category	178	182
Distribution services
Disaggregation of Revenue [Line Items]
Revenues disaggregated by category	70	72
Other income
Disaggregation of Revenue [Line Items]
Revenues disaggregated by category	$ 5	$ 7

INVESTMENTS - Available-for-sal

INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 44,926	$ 42,492
Gross Unrealized Gains	1,438	618
Gross Unrealized Losses	435	1,195
Fair Value	45,929	41,915
OTTI in AOCI	2	2
Amortized Cost
Subtotal	43,711
Fair Value
Subtotal	44,694
March 31, 2019	45,929
Corporate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	30,106	26,690
Gross Unrealized Gains	867	385
Gross Unrealized Losses	208	699
Fair Value	30,765	26,376
OTTI in AOCI	0	0
U.S. Treasury, government and agency
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	12,719	13,646
Gross Unrealized Gains	462	143
Gross Unrealized Losses	213	454
Fair Value	12,968	13,335
OTTI in AOCI	0	0
State and Political Sub-divisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	408	408
Gross Unrealized Gains	55	47
Gross Unrealized Losses	0	1
Fair Value	463	454
OTTI in AOCI	0	0
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	478	515
Gross Unrealized Gains	27	17
Gross Unrealized Losses	7	13
Fair Value	498	519
OTTI in AOCI	0	0
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	185	193
Gross Unrealized Gains	10	9
Gross Unrealized Losses	0	0
Fair Value	195	202
OTTI in AOCI	0	0
Amortized Cost
Without single maturity date	185
Fair Value
Without single maturity date	195
Asset- backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	608	600
Gross Unrealized Gains	1	1
Gross Unrealized Losses	4	11
Fair Value	605	590
OTTI in AOCI	2	2
Amortized Cost
Without single maturity date	608
Fair Value
Without single maturity date	605
Redeemable preferred stock
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	422	440
Gross Unrealized Gains	16	16
Gross Unrealized Losses	3	17
Fair Value	435	439
OTTI in AOCI	0	$ 0
Amortized Cost
Without single maturity date	422
Fair Value
Without single maturity date	435
Total Fixed Maturities
Amortized Cost
Due in one year or less	1,817
Due in years two through five	10,322
Due in years six through ten	14,953
Due after ten years	16,619
Fair Value
Due in one year or less	1,829
Due in years two through five	10,519
Due in years six through ten	15,367
Due after ten years	$ 16,979

INVESTMENTS - Credit Loss Impai

INVESTMENTS - Credit Loss Impairments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Proceeds from sales	$ 1,361	$ 3,428
Gross gains on sales	8	127
Gross losses on sales	(15)	(41)
Total OTTI	0	0
Non-credit losses recognized in OCI	0	0
Credit losses recognized in Net income (loss)	0	0
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning of year	12,428	19,492
End of year	12,370	18,492
Accumulated Other-than-Temporary Impairment Attributable to Parent [Member] | Fixed Maturities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning of year	(46)	(10)
Previously recognized impairments on securities that matured, paid, prepaid or sold	28	0
Recognized impairments on securities impaired to fair value this period	0	0
Impairments recognized this period on securities not previously impaired	0	0
Additional impairments this period on securities previously impaired	0	0
Increases due to passage of time on previously recorded credit losses	0	0
Accretion of previously recognized impairments due to increases in expected cash flows	0	0
End of year	$ (18)	$ (10)

INVESTMENTS - Net Unrealized In

INVESTMENTS - Net Unrealized Investment Gains (Losses) (Details) - Net Unrealized Gains (Losses) on Investments - Fixed Maturities - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Unrealized Net Investment Gain and Losses [Line Items]
Net unrealized gains (losses)	$ 1,003	$ (577)
With OTTI loss
Unrealized Net Investment Gain and Losses [Line Items]
Net unrealized gains (losses)	0	0
All other
Unrealized Net Investment Gain and Losses [Line Items]
Net unrealized gains (losses)	$ 1,003	$ (577)

INVESTMENTS - Rollforward of Ne

INVESTMENTS - Rollforward of Net Unrealized Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	$ 12,428	$ 19,492
Deferred income taxes	(200)	197
End of year	12,370	18,492
Accumulated Net Investment Gain (Loss) Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	(468)	679
Net investment gains (losses) arising during the period	1,583	(1,245)
Included in Net income (loss)	(3)	(88)
DAC	(655)	288
Deferred income taxes	(211)	197
Policyholders’ liabilities	77	108
End of year	323	(61)
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Net Unrealized Gains (Losses) on Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	(577)	1,526
Net investment gains (losses) arising during the period	1,583	(1,245)
Included in Net income (loss)	(3)	(88)
End of year	1,003	193
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | DAC
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	39	(315)
DAC	(655)	288
End of year	(616)	(27)
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Policyholders’ Liabilities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	(55)	(232)
Policyholders’ liabilities	77	108
End of year	22	(124)
Accumulated Net Investment Gain (Loss) Attributable to Parent | All other | Deferred Income Tax Asset (Liability)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	125	(300)
Deferred income taxes	(211)	197
End of year	(86)	(103)
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	0	(4)
Net investment gains (losses) arising during the period	(10)	0
Included in Net income (loss)	10	(2)
DAC	0	(1)
Deferred income taxes	0	0
Policyholders’ liabilities	0	1
End of year	0	(6)
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Net Unrealized Gains (Losses) on Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	0	1
Net investment gains (losses) arising during the period	(10)	0
End of year	0	(1)
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | DAC
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	0	1
DAC	0	(1)
End of year	0	0
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Policyholders’ Liabilities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	0	(1)
Policyholders’ liabilities	0	1
End of year	0	0
Accumulated Net Investment Gain (Loss) Attributable to Parent | Fixed Maturities | With OTTI loss | Deferred Income Tax Asset (Liability)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning of year	0	(5)
Deferred income taxes	0	0
End of year	$ 0	$ (5)

INVESTMENTS - Gross Unrealized

INVESTMENTS - Gross Unrealized Losses (Details) $ in Millions	Mar. 31, 2019USD ($)security	Dec. 31, 2018USD ($)security
Investments, Debt and Equity Securities [Abstract]
Number of fixed maturities in an unrealized loss position greater than 12 months | security	674	1,471
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	$ 976	$ 11,832
Less Than 12 Months, Gross Unrealized Losses	8	400
Greater than 12 Months, Fair Value	8,901	9,460
Greater Than 12 Months, Gross Unrealized Losses	427	795
Total, Fair Value	9,877	21,292
Total, Gross Unrealized Losses	435	1,195
Corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	653	8,369
Less Than 12 Months, Gross Unrealized Losses	6	306
Greater than 12 Months, Fair Value	5,387	6,161
Greater Than 12 Months, Gross Unrealized Losses	202	393
Total, Fair Value	6,040	14,530
Total, Gross Unrealized Losses	208	699
U.S. Treasury, government and agency
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	0	2,636
Less Than 12 Months, Gross Unrealized Losses	0	68
Greater than 12 Months, Fair Value	3,163	3,154
Greater Than 12 Months, Gross Unrealized Losses	213	386
Total, Fair Value	3,163	5,790
Total, Gross Unrealized Losses	213	454
State and Political Sub-divisions
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value		0
Less Than 12 Months, Gross Unrealized Losses		0
Greater than 12 Months, Fair Value		19
Greater Than 12 Months, Gross Unrealized Losses		1
Total, Fair Value		19
Total, Gross Unrealized Losses		1
Foreign governments
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	0	109
Less Than 12 Months, Gross Unrealized Losses	0	3
Greater than 12 Months, Fair Value	67	76
Greater Than 12 Months, Gross Unrealized Losses	7	10
Total, Fair Value	67	185
Total, Gross Unrealized Losses	7	13
Residential mortgage-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value		0
Less Than 12 Months, Gross Unrealized Losses		0
Greater than 12 Months, Fair Value		13
Greater Than 12 Months, Gross Unrealized Losses		0
Total, Fair Value		13
Total, Gross Unrealized Losses		0
Asset- backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	279	558
Less Than 12 Months, Gross Unrealized Losses	1	11
Greater than 12 Months, Fair Value	249	6
Greater Than 12 Months, Gross Unrealized Losses	3	0
Total, Fair Value	528	564
Total, Gross Unrealized Losses	4	11
Redeemable preferred stock
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	44	160
Less Than 12 Months, Gross Unrealized Losses	1	12
Greater than 12 Months, Fair Value	35	31
Greater Than 12 Months, Gross Unrealized Losses	2	5
Total, Fair Value	79	191
Total, Gross Unrealized Losses	$ 3	$ 17

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details) $ in Millions	Mar. 31, 2019USD ($)security	Dec. 31, 2018USD ($)security
Debt Securities, Available-for-sale [Line Items]
Number of fixed maturities in an unrealized loss position greater than 12 months | security	674	1,471
Securities sold under agreements to repurchase	$ 0	$ 573
Debt securities exposure in single issuer greater than stated percentage of total investments	0.70%
AOCI Unrealized gain (loss) on AFS securities	$ (5)	(30)
Gross unrealized losses of twelve months or more	427	795
Trading securities, at fair value	12,704	15,166
Separate account equity investment carrying value	50	48
Corporate
Debt Securities, Available-for-sale [Line Items]
Debt securities exposure in single issuer of total investments	$ 218	$ 210
Debt securities exposure in single issuer of total investments, percent	1.80%	1.70%
Fixed Maturities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, amortized cost basis	$ 44,926	$ 42,492
External Credit Rating, Non Investment Grade [Member] | Fixed Maturities | Other Than Investment Grade
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, amortized cost	$ 1,250	$ 1,228
Percentage of available for sale securities	2.80%	2.90%
Total Commercial Mortgage Loans
Debt Securities, Available-for-sale [Line Items]
Mortgage loans classified as nonaccrual	$ 0	$ 19

INVESTMENTS - Trading Securitie

INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Debt Securities, Trading, Gain (Loss) [Abstract]
Net investment gains (losses) recognized during the period on securities held at the end of the period	$ 274	$ (96)
Net investment gains (losses) recognized on securities sold during the period	(24)	(1)
Unrealized and realized gains (losses) on trading securities arising during the period	250	(97)
Interest and dividend income from trading securities	90	66
Net investment income (loss) from trading securities	$ 340	$ (31)

INVESTMENTS - Valuation Allowan

INVESTMENTS - Valuation Allowance for Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually evaluated for impairment	$ 0		$ 7
Total Commercial Mortgage Loans
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning balance, January 1	7	$ 8
Charge-offs	(7)	0
Recoveries	0	(1)
Provision	0	0
Ending balance, March 31,	0	7
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually evaluated for impairment	$ 0	$ 7

INVESTMENTS - Mortgage Loans (D

INVESTMENTS - Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	$ 2	$ 2
Unpaid Principal Balance	2	2
Related Allowance	0	0
Average Recorded Investment	2	0
Interest Income Recognized	0	0
With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	27
Unpaid Principal Balance	0	31
Related Allowance	0	(7)
Average Recorded Investment	13	27
Interest Income Recognized	0	0
Total Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	9,370	9,130
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	27
Financing receivables, recorded investment, current	9,370	9,103
Total Financing Receivables	9,370	9,130
Financing receivable, recorded investment, 90 days or more past due and accruing	0	0
Total Commercial Mortgage Loans | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	27
Unpaid Principal Balance	0	31
Related Allowance	0	(7)
Average Recorded Investment	13	27
Interest Income Recognized	0	0
Total Commercial Mortgage Loans | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Total Commercial Mortgage Loans | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Total Commercial Mortgage Loans | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	27
Total Commercial Mortgage Loans | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	5,963	5,948
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	5,963	5,948
Total Commercial Mortgage Loans | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	827	677
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	827	677
Total Commercial Mortgage Loans | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,616	1,510
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,616	1,510
Total Commercial Mortgage Loans | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	832	746
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	832	746
Total Commercial Mortgage Loans | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	132	249
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	132	249
Total Commercial Mortgage Loans | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,024	1,072
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,024	1,072
Total Commercial Mortgage Loans | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	764	780
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	764	780
Total Commercial Mortgage Loans | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	21	21
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	21	21
Total Commercial Mortgage Loans | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	215	247
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	215	247
Total Commercial Mortgage Loans | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	24	24
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	24	24
Total Commercial Mortgage Loans | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	7,497	7,186
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	7,497	7,186
Total Commercial Mortgage Loans | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	4,933	4,908
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	4,933	4,908
Total Commercial Mortgage Loans | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	806	656
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	806	656
Total Commercial Mortgage Loans | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,284	1,146
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,284	1,146
Total Commercial Mortgage Loans | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	474	325
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	474	325
Total Commercial Mortgage Loans | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	151
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	151
Total Commercial Mortgage Loans | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	849	845
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	849	845
Total Commercial Mortgage Loans | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	266	260
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	266	260
Total Commercial Mortgage Loans | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	117	117
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	117	117
Total Commercial Mortgage Loans | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	334	370
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	334	370
Total Commercial Mortgage Loans | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	132	98
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	132	98
Total Commercial Mortgage Loans | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27
Total Commercial Mortgage Loans | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27
Total Commercial Mortgage Loans | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Commercial Mortgage Loans | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	2,730	2,695
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	90	68
Financing receivables, recorded investment, current	2,640	2,627
Total Financing Receivables	2,730	2,695
Financing receivable, recorded investment, 90 days or more past due and accruing	54	40
Total Agricultural Mortgage Loans | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	2	2
Unpaid Principal Balance	2	2
Related Allowance	0	0
Average Recorded Investment	2	0
Interest Income Recognized	0	0
Total Agricultural Mortgage Loans | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	9	18
Total Agricultural Mortgage Loans | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	26	8
Total Agricultural Mortgage Loans | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	55	42
Total Agricultural Mortgage Loans | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	397	394
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	397	394
Total Agricultural Mortgage Loans | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	200	193
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	200	193
Total Agricultural Mortgage Loans | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	524	513
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	524	513
Total Agricultural Mortgage Loans | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	939	941
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	939	941
Total Agricultural Mortgage Loans | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	587	572
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	587	572
Total Agricultural Mortgage Loans | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	83	82
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	83	82
Total Agricultural Mortgage Loans | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,646	1,611
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,646	1,611
Total Agricultural Mortgage Loans | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	278	282
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	278	282
Total Agricultural Mortgage Loans | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	130	147
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	130	147
Total Agricultural Mortgage Loans | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	276	267
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	276	267
Total Agricultural Mortgage Loans | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	563	543
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	563	543
Total Agricultural Mortgage Loans | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	350	321
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	350	321
Total Agricultural Mortgage Loans | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	49	51
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	49	51
Total Agricultural Mortgage Loans | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,065	1,038
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,065	1,038
Total Agricultural Mortgage Loans | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	119	112
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	119	112
Total Agricultural Mortgage Loans | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	70	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	70	46
Total Agricultural Mortgage Loans | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	248	246
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	248	246
Total Agricultural Mortgage Loans | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	357	379
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	357	379
Total Agricultural Mortgage Loans | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	237	224
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	237	224
Total Agricultural Mortgage Loans | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	34	31
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	34	31
Total Agricultural Mortgage Loans | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	19	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	19	46
Total Agricultural Mortgage Loans | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	19	19
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	19	19
Total Agricultural Mortgage Loans | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27
Total Agricultural Mortgage Loans | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Agricultural Mortgage Loans | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	12,100	11,825
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	90	95
Financing receivables, recorded investment, current	12,010	11,730
Total Financing Receivables	12,100	11,825
Financing receivable, recorded investment, 90 days or more past due and accruing	54	40
Total Mortgage Loans | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	9	18
Total Mortgage Loans | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	26	8
Total Mortgage Loans | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	55	69
Total Mortgage Loans | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	6,360	6,342
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	6,360	6,342
Total Mortgage Loans | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,027	870
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,027	870
Total Mortgage Loans | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	2,140	2,023
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	2,140	2,023
Total Mortgage Loans | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,771	1,687
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,771	1,687
Total Mortgage Loans | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	719	821
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	719	821
Total Mortgage Loans | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	83	82
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	83	82
Total Mortgage Loans | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	2,670	2,683
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	2,670	2,683
Total Mortgage Loans | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,042	1,062
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,042	1,062
Total Mortgage Loans | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	151	168
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	151	168
Total Mortgage Loans | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	491	514
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	491	514
Total Mortgage Loans | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	587	567
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	587	567
Total Mortgage Loans | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	350	321
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	350	321
Total Mortgage Loans | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	49	51
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	49	51
Total Mortgage Loans | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	8,562	8,224
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	8,562	8,224
Total Mortgage Loans | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	5,052	5,020
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	5,052	5,020
Total Mortgage Loans | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	876	702
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	876	702
Total Mortgage Loans | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	1,532	1,392
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,532	1,392
Total Mortgage Loans | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	831	704
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	831	704
Total Mortgage Loans | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	237	375
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	237	375
Total Mortgage Loans | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	34	31
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	34	31
Total Mortgage Loans | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	868	891
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	868	891
Total Mortgage Loans | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	266	260
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	266	260
Total Mortgage Loans | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	117	117
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	117	117
Total Mortgage Loans | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	353	389
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	353	389
Total Mortgage Loans | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	132	125
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	132	125
Total Mortgage Loans | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27
Total Mortgage Loans | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27
Total Mortgage Loans | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgage Loans | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total Mortgage Loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	$ 0	$ 0

DERIVATIVES - Derivatives by Ca

DERIVATIVES - Derivatives by Category (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Notional Amount	$ 99,602		$ 81,636
Fair Value, Assets Derivatives	6,470		4,936
Net Amount Presented in the Balance Sheets	12,383		9,226
Gains (Losses) Reported In Net Income (Loss)	(1,555)	$ (817)
Equity Futures
Derivatives, Fair Value [Line Items]
Notional Amount	6,544		10,411
Fair Value, Assets Derivatives	0		0
Net Amount Presented in the Balance Sheets	0		0
Gains (Losses) Reported In Net Income (Loss)	(738)	(29)
Equity Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	8,065		7,697
Fair Value, Assets Derivatives	6		140
Net Amount Presented in the Balance Sheets	371		168
Gains (Losses) Reported In Net Income (Loss)	(973)	64
Equity Option
Derivatives, Fair Value [Line Items]
Notional Amount	37,417		21,698
Fair Value, Assets Derivatives	3,474		2,119
Net Amount Presented in the Balance Sheets	1,310		1,163
Gains (Losses) Reported In Net Income (Loss)	1,101	(15)
Interest Rate Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	28,153		27,003
Fair Value, Assets Derivatives	910		632
Net Amount Presented in the Balance Sheets	209		194
Gains (Losses) Reported In Net Income (Loss)	648	(490)
Interest Rate Futures
Derivatives, Fair Value [Line Items]
Notional Amount	16,385		11,448
Fair Value, Assets Derivatives	0		0
Net Amount Presented in the Balance Sheets	0		0
Gains (Losses) Reported In Net Income (Loss)	55	40
Credit default swaps
Derivatives, Fair Value [Line Items]
Notional Amount	1,242		1,282
Fair Value, Assets Derivatives	22		17
Net Amount Presented in the Balance Sheets	0		0
Gains (Losses) Reported In Net Income (Loss)	10	0
Foreign Currency Contracts
Derivatives, Fair Value [Line Items]
Notional Amount	1,796		2,097
Fair Value, Assets Derivatives	24		27
Net Amount Presented in the Balance Sheets	1		14
Gains (Losses) Reported In Net Income (Loss)	10	(51)
Collateral
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Fair Value, Assets Derivatives	16		7
Net Amount Presented in the Balance Sheets	0		5
Gains (Losses) Reported In Net Income (Loss)	0	0
Margin
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Fair Value, Assets Derivatives	9		3
Net Amount Presented in the Balance Sheets	2,556		1,564
Gains (Losses) Reported In Net Income (Loss)	0	0
GMIB Reinsurance Contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Fair Value, Assets Derivatives	2,009		1,991
Net Amount Presented in the Balance Sheets	0		0
Gains (Losses) Reported In Net Income (Loss)	27	(842)
GMxB Derivative Features’ Liability
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Fair Value, Assets Derivatives	0		0
Net Amount Presented in the Balance Sheets	5,944		5,431
Gains (Losses) Reported In Net Income (Loss)	(409)	485
SCS, SIO, MSO and IUL Indexed Features
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Fair Value, Assets Derivatives	0		0
Net Amount Presented in the Balance Sheets	1,992		$ 687
Gains (Losses) Reported In Net Income (Loss)	$ (1,286)	$ 21

DERIVATIVES - Offsetting of Fin

DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 31, 2019
Securities Sold under Agreements to Repurchase
Net Amount Presented in the Balance Sheets	$ 573	$ 0
Interest expense, securities sold under agreements to repurchase	2
Total derivatives
Assets
Gross Amount Recognized	2,946	4,460
Gross Amount Offset in the Balance Sheets	2,912	4,399
Net Amount Presented in the Balance Sheets	34	61
Liabilities
Gross Amount Recognized	3,109	4,399
Gross Amount Offset in the Balance Sheets	2,912	4,352
Net Amount Presented in the Balance Sheets	197	47
Other financial instruments
Assets
Gross Amount Recognized	1,520	1,688
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,520	1,688
Other invested assets
Assets
Gross Amount Recognized	4,466	6,148
Gross Amount Offset in the Balance Sheets	2,912	4,399
Net Amount Presented in the Balance Sheets	1,554	1,749
Other financial liabilities
Liabilities
Gross Amount Recognized	1,263	1,553
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,263	1,553
Other liabilities
Liabilities
Gross Amount Recognized	4,372	5,952
Gross Amount Offset in the Balance Sheets	2,912	4,352
Net Amount Presented in the Balance Sheets	1,460	$ 1,600
Securities sold under agreement to repurchase
Securities Sold under Agreements to Repurchase
Gross Amount Recognized	571
Gross Amount Offset in Balance Sheets	0
Net Amount Presented in the Balance Sheets	$ 571

DERIVATIVES - Collateral Amount

DERIVATIVES - Collateral Amounts Not Offset in the Consolidated Balance Sheets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 31, 2019
Assets
Net Amount Presented in the Balance Sheets	$ 4,936	$ 6,470
Liabilities
Net Amount Presented in the Balance Sheets	9,226	12,383
Securities Sold under Agreements to Repurchase
Net Amount Presented in the Balance Sheets	573	0
Interest expense, securities sold under agreements to repurchase	2
Total derivatives
Assets
Net Amount Presented in the Balance Sheets	1,397	2,546
Collateral Held, Financial Instruments	0	367
Collateral (Received) Held, Cash	1,363	2,118
Net Amount	34	61
Liabilities
Net Amount Presented in the Balance Sheets	197	47
Collateral Held, Financial Instruments	0	0
Collateral Held, Cash	0	0
Net Amount	197	47
Other financial instruments
Assets
Net Amount Presented in the Balance Sheets	1,520	1,688
Collateral Held, Financial Instruments	0	0
Collateral (Received) Held, Cash	0	0
Net Amount	1,520	1,688
Other invested assets
Assets
Net Amount Presented in the Balance Sheets	2,917	4,234
Collateral Held, Financial Instruments	0	367
Collateral (Received) Held, Cash	1,363	2,118
Net Amount	1,554	1,749
Other financial liabilities
Liabilities
Net Amount Presented in the Balance Sheets	1,263	1,553
Collateral Held, Financial Instruments	0	0
Collateral Held, Cash	0	0
Net Amount	1,263	1,553
Other liabilities
Liabilities
Net Amount Presented in the Balance Sheets	1,460	1,600
Collateral Held, Financial Instruments	0	0
Collateral Held, Cash	0	0
Net Amount	1,460	$ 1,600
Securities sold under agreement to repurchase
Securities Sold under Agreements to Repurchase
Net Amount Presented in the Balance Sheets	571
Collateral Held, Financial Instruments	(588)
Collateral Held, Cash	0
Net Amount	$ (17)

DERIVATIVES - Narrative (Detail

DERIVATIVES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Proceeds from sale of treasury stock	$ 3,905
Net Amount Presented in the Balance Sheets	12,383	$ 9,226
Derivative, Net Liability Position, Aggregate Fair Value	9	3
Securities Sold under Agreements to Repurchase	0	573
US Treasury Securities
Derivative [Line Items]
Marketable securities	3,788
Total Return Swap
Derivative [Line Items]
Marketable securities	87
Collateral Contracts [Member]
Derivative [Line Items]
Net Amount Presented in the Balance Sheets	2,556	$ 1,564
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Derivative [Line Items]
Initial margin requirements	256
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Derivative [Line Items]
Initial margin requirements	34
Euro Stoxx, FTSE100, EAFE And Topix Indices
Derivative [Line Items]
Initial margin requirements	$ 25

DERIVATIVES - Repurchase Agreem

DERIVATIVES - Repurchase Agreements (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	$ 571
Interest expense, securities sold under agreements to repurchase	2
Overnight and Continuous
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	0
Up to 30 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	571
30–90 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	0
Greater Than 90 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	0
U.S. Treasury, government and agency
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	571
U.S. Treasury, government and agency | Overnight and Continuous
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	0
U.S. Treasury, government and agency | Up to 30 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	571
U.S. Treasury, government and agency | 30–90 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	0
U.S. Treasury, government and agency | Greater Than 90 days
Assets Sold under Agreements to Repurchase [Line Items]
Remaining Contractual Maturity of the Agreements	$ 0

CLOSED BLOCK - Summarized Finan

CLOSED BLOCK - Summarized Financial Information for Closed Block (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other	$ 6,670	$ 6,709
Policyholder dividend obligation	0	0	$ 0	$ 19
Other liabilities	70	47
Total Closed Block liabilities	6,740	6,756
Assets Designated to the Closed Block:
Fixed maturities, available-for-sale, at fair value (amortized cost of $3,606 and $3,680)	3,697	3,672
Fixed maturities, available for sale, amortized cost	3,606	3,680
Mortgage loans on real estate, net of valuation allowance of $0 and $0	1,822	1,824
Mortgage loan valuation allowance	0	0
Policy loans	727	736
Cash and other invested assets	142	76
Other assets	171	179
Total assets designated to the Closed Block	6,559	6,487
Excess of Closed Block liabilities over assets designated to the Closed Block	181	269
Amounts included in accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $0 and $0	105	8
Maximum future earnings to be recognized from Closed Block assets and liabilities	$ 286	$ 277

CLOSED BLOCK - Revenues and Exp

CLOSED BLOCK - Revenues and Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Premiums and other income	$ 48	$ 51
Net investment income (loss)	67	73
Investment gains (losses), net	(1)	1
Total revenues	114	125
Benefits and Other Deductions:
Policyholders’ benefits and dividends	121	126
Other operating costs and expenses	1	1
Total benefits and other deductions	122	127
Net income (loss) before income taxes	(8)	(2)
Income tax (expense) benefit	(1)	0
Net income (loss)	$ (9)	$ (2)

CLOSED BLOCK - Reconciliation o

CLOSED BLOCK - Reconciliation of Policyholder Dividend Obligation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Movement in Closed Block Dividend Obligation [Roll Forward]
Balances, beginning of year	$ 0	$ 19
Unrealized investment gains (losses), net of DAC	0	(19)
Balances, end of period	$ 0	$ 0

INSURANCE LIABILITIES - GMDB an

INSURANCE LIABILITIES - GMDB and GMIB Liabilities and Other Policyholder's Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
GMDB Direct [Member]
Direct Liability
Balance, beginning of period	$ 4,654	$ 4,054
Paid guarantee benefits	(118)	(101)
Other changes in reserves	129	96
Balance, end of period	4,665	4,049
GMDB
Direct Liability
Balance, beginning of period	(107)	(2,030)
Paid guarantee benefits	4	(54)
Other changes in reserves	0	62
Balance, end of period	(103)	(2,022)
GMIB Direct [Member]
Direct Liability
Balance, beginning of period	3,741	4,754
Paid guarantee benefits	(56)	(32)
Other changes in reserves	55	(139)
Balance, end of period	3,740	4,583
GMIB Ceded [Member]
Direct Liability
Balance, beginning of period	(1,991)	(10,488)
Paid guarantee benefits	21	27
Other changes in reserves	(39)	788
Balance, end of period	$ (2,009)	$ (9,673)

INSURANCE LIABILITIES - GMDB Re

INSURANCE LIABILITIES - GMDB Reinsurance Ceded (Details) - GMDB - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward]
Balance, beginning of year	$ 107	$ 2,030
Paid guarantee benefits	4	(54)
Other changes in reserve	0	(62)
Balance, end of period	$ 103	$ 2,022

INSURANCE LIABILITIES - Variabl

INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 14,517
Account Value Invested In Separate Accounts	90,343	$ 83,154
Net Amount At Risk By Product And Guarantee, Account Value	104,860
Net amount at risk, gross	20,700
Net amount at risk, net of amounts reinsured	$ 20,084
Average attained age of policyholders (in years)	55 years 3 months 19 days
Percentage of policyholders over age 70	19.00%
GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
GMDB | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 14,178
Account Value Invested In Separate Accounts	45,599
Net Amount At Risk By Product And Guarantee, Account Value	59,777
Net amount at risk, gross	143
Net amount at risk, net of amounts reinsured	$ 143
Average attained age of policyholders (in years)	51 years 4 months 24 days
Percentage of policyholders over age 70	10.20%
GMDB | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 98
Account Value Invested In Separate Accounts	9,001
Net Amount At Risk By Product And Guarantee, Account Value	9,099
Net amount at risk, gross	143
Net amount at risk, net of amounts reinsured	$ 138
Average attained age of policyholders (in years)	67 years 1 month 6 days
Percentage of policyholders over age 70	43.50%
GMDB | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 60
Account Value Invested In Separate Accounts	3,134
Net Amount At Risk By Product And Guarantee, Account Value	3,194
Net amount at risk, gross	2,025
Net amount at risk, net of amounts reinsured	$ 1,414
Average attained age of policyholders (in years)	73 years 9 months 18 days
Percentage of policyholders over age 70	66.10%
GMDB | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMDB | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.00%
GMDB | Combo
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 181
Account Value Invested In Separate Accounts	32,609
Net Amount At Risk By Product And Guarantee, Account Value	32,790
Net amount at risk, gross	18,389
Net amount at risk, net of amounts reinsured	$ 18,389
Average attained age of policyholders (in years)	69 years 2 months 12 days
Percentage of policyholders over age 70	50.70%
GMDB | Combo | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMDB | Combo | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 264
Account Value Invested In Separate Accounts	57,668	$ 52,835
Net Amount At Risk By Product And Guarantee, Account Value	57,932
Net amount at risk, gross	9,185
Net amount at risk, net of amounts reinsured	$ 7,796
Average attained age of policyholders (in years)	69 years
Weighted average years remaining until annuitization	6 months
GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
GMIB | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 0
Account Value Invested In Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net amount at risk, gross	0
Net amount at risk, net of amounts reinsured	0
GMIB | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	0
Account Value Invested In Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net amount at risk, gross	0
Net amount at risk, net of amounts reinsured	0
GMIB | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	19
Account Value Invested In Separate Accounts	21,923
Net Amount At Risk By Product And Guarantee, Account Value	21,942
Net amount at risk, gross	898
Net amount at risk, net of amounts reinsured	$ 281
Average attained age of policyholders (in years)	69 years
Weighted average years remaining until annuitization	1 year 8 months 12 days
GMIB | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMIB | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.00%
GMIB | Combo
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 245
Account Value Invested In Separate Accounts	35,745
Net Amount At Risk By Product And Guarantee, Account Value	35,990
Net amount at risk, gross	8,287
Net amount at risk, net of amounts reinsured	$ 7,515
Average attained age of policyholders (in years)	69 years
Weighted average years remaining until annuitization	4 months 24 days
GMIB | Combo | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
GMIB | Combo | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%

INSURANCE LIABILITIES - Investm

INSURANCE LIABILITIES - Investment in Variable Insurance Trust Mutual Funds (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	$ 90,343	$ 83,154
GMDB | Equity
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	39,856	35,541
GMDB | Fixed income
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	5,206	5,173
GMDB | Balanced
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	44,433	41,588
GMDB | Other
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	848	852
GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	57,668	52,835
GMIB | Equity
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	17,692	15,759
GMIB | Fixed income
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	2,825	2,812
GMIB | Balanced
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	36,855	33,974
GMIB | Other
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Investment in Variable Insurance Trust Mutual Funds	$ 296	$ 290

INSURANCE LIABILITIES - Summary

INSURANCE LIABILITIES - Summary of No-Lapse Guarantee Liabilities and Other Policyholder's Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Direct Liability
Direct Liability
Balance, beginning of period	$ 787	$ 692
Paid guaranteed benefits	(7)	(8)
Other changes in reserves	21	18
Balance, end of period	801	702
Reinsurance Ceded
Direct Liability
Balance, beginning of period	(733)	(664)
Paid guaranteed benefits	0	0
Other changes in reserves	(11)	(11)
Balance, end of period	(744)	(675)
Net
Direct Liability
Balance, beginning of period	54	28
Paid guaranteed benefits	(7)	(8)
Other changes in reserves	10	7
Balance, end of period	$ 57	$ 27

FAIR VALUE DISCLOSURES - Assets

FAIR VALUE DISCLOSURES - Assets and Liabilities Measure at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Assets
Fair Value	$ 45,929	$ 41,915
Trading account securities	12,704	15,166
Fair Value, Measurements, Recurring
Assets
Fair Value	45,929	41,915
Other equity investments	12	12
Trading account securities	12,704	15,166
Other invested assets	2,762	1,827
Cash equivalents	2,518	2,160
GMIB reinsurance contract asset	2,009	1,991
Separate Accounts assets	117,913	108,266
Total Assets	183,847	171,337
Liabilities
Total Liabilities	7,936	6,118
Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	157	163
Other equity investments	12	12
Trading account securities	296	218
Other invested assets	0	0
Cash equivalents	2,518	2,160
GMIB reinsurance contract asset	0	0
Separate Accounts assets	114,780	105,159
Total Assets	117,763	107,712
Liabilities
Total Liabilities	0	0
Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	44,030	40,021
Other equity investments	0	0
Trading account securities	12,408	14,919
Other invested assets	2,744	1,808
Cash equivalents	0	0
GMIB reinsurance contract asset	0	0
Separate Accounts assets	2,750	2,733
Total Assets	61,932	59,481
Liabilities
Total Liabilities	1,992	687
Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	1,742	1,731
Other equity investments	0	0
Trading account securities	0	29
Other invested assets	18	19
Cash equivalents	0	0
GMIB reinsurance contract asset	2,009	1,991
Separate Accounts assets	383	374
Total Assets	4,152	4,144
Liabilities
Total Liabilities	5,944	5,431
Redeemable preferred stock
Assets
Fair Value	435	439
Redeemable preferred stock | Fair Value, Measurements, Recurring
Assets
Fair Value	435	439
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	157	163
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	278	276
Redeemable preferred stock | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	0	0
Asset- backed
Assets
Fair Value	605	590
Asset- backed | Fair Value, Measurements, Recurring
Assets
Fair Value	605	590
Asset- backed | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
Asset- backed | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	71	71
Asset- backed | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	534	519
Foreign governments
Assets
Fair Value	498	519
Foreign governments | Fair Value, Measurements, Recurring
Assets
Fair Value	498	519
Foreign governments | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
Foreign governments | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	498	519
Foreign governments | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	0	0
State and Political Sub-divisions
Assets
Fair Value	463	454
State and Political Sub-divisions | Fair Value, Measurements, Recurring
Assets
Fair Value	463	454
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	424	416
State and Political Sub-divisions | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	39	38
U.S. Treasury, government and agency
Assets
Fair Value	12,968	13,335
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring
Assets
Fair Value	12,968	13,335
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	12,968	13,335
U.S. Treasury, government and agency | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	0	0
Public Corporate [Member] | Fair Value, Measurements, Recurring
Assets
Fair Value	30,765	26,376
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	29,596	25,202
Public Corporate [Member] | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	1,169	1,174
Residential Mortgage Backed Securities [Member]
Assets
Fair Value	195	202
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring
Assets
Fair Value	195	202
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 1
Assets
Fair Value	0	0
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 2
Assets
Fair Value	195	202
Residential Mortgage Backed Securities [Member] | Fair Value, Measurements, Recurring | Level 3
Assets
Fair Value	0	0
Short-term investments | Fair Value, Measurements, Recurring
Assets
Other invested assets	198	412
Short-term investments | Fair Value, Measurements, Recurring | Level 1
Assets
Other invested assets	0	0
Short-term investments | Fair Value, Measurements, Recurring | Level 2
Assets
Other invested assets	198	412
Short-term investments | Fair Value, Measurements, Recurring | Level 3
Assets
Other invested assets	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring
Assets
Other invested assets	18	19
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 1
Assets
Other invested assets	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 2
Assets
Other invested assets	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Measurements, Recurring | Level 3
Assets
Other invested assets	18	19
Swaps | Fair Value, Measurements, Recurring
Assets
Other invested assets	360	423
Swaps | Fair Value, Measurements, Recurring | Level 1
Assets
Other invested assets	0	0
Swaps | Fair Value, Measurements, Recurring | Level 2
Assets
Other invested assets	360	423
Swaps | Fair Value, Measurements, Recurring | Level 3
Assets
Other invested assets	0	0
Credit default swaps | Fair Value, Measurements, Recurring
Assets
Other invested assets	22	17
Credit default swaps | Fair Value, Measurements, Recurring | Level 1
Assets
Other invested assets	0	0
Credit default swaps | Fair Value, Measurements, Recurring | Level 2
Assets
Other invested assets	22	17
Credit default swaps | Fair Value, Measurements, Recurring | Level 3
Assets
Other invested assets	0	0
Options | Fair Value, Measurements, Recurring
Assets
Other invested assets	2,164	956
Options | Fair Value, Measurements, Recurring | Level 1
Assets
Other invested assets	0	0
Options | Fair Value, Measurements, Recurring | Level 2
Assets
Other invested assets	2,164	956
Options | Fair Value, Measurements, Recurring | Level 3
Assets
Other invested assets	0	0
GMxB derivative features’ liability | Fair Value, Measurements, Recurring
Liabilities
Features’ liability	5,944	5,431
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 1
Liabilities
Features’ liability	0	0
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 2
Liabilities
Features’ liability	0	0
GMxB derivative features’ liability | Fair Value, Measurements, Recurring | Level 3
Liabilities
Features’ liability	5,944	5,431
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring
Liabilities
Features’ liability	1,992	687
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 1
Liabilities
Features’ liability	0	0
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 2
Liabilities
Features’ liability	1,992	687
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Measurements, Recurring | Level 3
Liabilities
Features’ liability	$ 0	$ 0

FAIR VALUE DISCLOSURES - Narrat

FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fair value adjustments on GMIB asset	$ 148	$ 184
Transfers out of Level 3	69	16
Transfers into level 3	$ 17	$ 67
Transfers out of Levels 2 and 3 to total equity (as a percent)	0.70%	0.40%
Level 3 | Corporate | Matrix pricing model
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fair value of privately placed, available-for-sale corporate debt securities classified as Level 3	$ 96		$ 93
Level 3 | Separate Accounts Assets | Third party appraisal
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fair value of privately placed, available-for-sale corporate debt securities classified as Level 3	359		352
Fair Value, Measurements, Nonrecurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fair Value Measurements Not Included In Quantitative Information About Level 3 Fair Value Measurements	$ 796		$ 826

FAIR VALUE DISCLOSURES - Level

FAIR VALUE DISCLOSURES - Level 3 Unobservable Input Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Total gains (losses), realized and unrealized, included in:
Transfers into level 3	$ 17	$ 67
Transfers out of Level 3	(69)	(16)
Corporate | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	1,174	1,139
Total gains (losses), realized and unrealized, included in:
Investment Income, Net	1
Net investment income (loss)		2
Other comprehensive income (loss)	9	(20)
Purchases	70	173
Sales	(33)	116
Transfers into level 3	17	67
Transfers out of Level 3	(69)	16
Closing Balance	1,169	1,229
Asset- backed | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	519	8
Total gains (losses), realized and unrealized, included in:
Investment Income, Net	0
Net investment income (loss)		0
Other comprehensive income (loss)	4	0
Purchases	11	0
Sales	0	1
Transfers into level 3	0	0
Transfers out of Level 3	0	0
Closing Balance	534	7
State and Political Sub-divisions | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	38	40
Total gains (losses), realized and unrealized, included in:
Investment Income, Net	0
Net investment income (loss)		0
Other comprehensive income (loss)	1	(1)
Purchases	0	0
Sales	0	0
Transfers into level 3	0	0
Transfers out of Level 3	0	0
Closing Balance	39	39
Other Equity Investments | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	48	25
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net	0	0
Net derivative gains (losses)	0	0
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk	0	0
Subtotal	0	0
Purchases	0	0
Sales	0	0
Settlements	0	0
Activity related to consolidated VIEs	(1)	1
Transfers into level 3		5
Transfers out of Level 3	(29)
Closing Balance	18	31
GMIB Reinsurance Asset | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	1,991	10,488
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net	0	0
Net derivative gains (losses)	(13)	(854)
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk	40	13
Subtotal	27	(841)
Purchases	12	54
Sales	(21)	27
Settlements	0	0
Activity related to consolidated VIEs	0	0
Transfers into level 3		0
Transfers out of Level 3	0
Closing Balance	2,009	9,674
Separate Accounts Assets | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	374	349
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net	7	7
Net derivative gains (losses)	0	0
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk	0	0
Subtotal	7	7
Purchases	4	3
Sales	0	1
Settlements	(1)	1
Activity related to consolidated VIEs	0	0
Transfers into level 3		0
Transfers out of Level 3	(1)
Closing Balance	383	357
GMxB derivative features liability | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance	(5,431)
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net	0
Net derivative gains (losses)	51
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk	(460)
Subtotal	(409)
Purchases	(107)
Sales	3
Settlements	0
Activity related to consolidated VIEs	0
Transfers out of Level 3	0
GMxB Derivative Features Liability | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening Balance		(4,256)
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net		0
Net derivative gains (losses)		436
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Nonperformance Risk		49
Subtotal		485
Purchases		(93)
Sales		(2)
Settlements		0
Activity related to consolidated VIEs		0
Transfers into level 3		0
Closing Balance	$ (5,944)	$ (3,862)

FAIR VALUE DISCLOSURES - Unreal

FAIR VALUE DISCLOSURES - Unrealized Gains (Losses) for Level 3 Still Held (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	$ (8)	$ 87
Level 3 | Corporate
Change in Accounting Estimate [Line Items]
OCI	9	(20)
Level 3 | States and political subdivisions
Change in Accounting Estimate [Line Items]
OCI	1	(1)
Level 3 | Asset-backed
Change in Accounting Estimate [Line Items]
OCI	4	0
Level 3 | GMIB reinsurance contracts
Change in Accounting Estimate [Line Items]
Net Derivative Gains (Losses)	0	0
Level 3 | Separate Accounts Assets
Change in Accounting Estimate [Line Items]
Net Derivative Gains (Losses)	7	7
Level 3 | GMxB derivative features liability
Change in Accounting Estimate [Line Items]
Net Derivative Gains (Losses)	0
Level 3 | Continuing Operations | Corporate
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	9	(19)
Level 3 | Continuing Operations | States and political subdivisions
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	1	(1)
Level 3 | Continuing Operations | Asset-backed
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0
Net Derivative Gains (Losses)	0
OCI	4
Level 3 | Continuing Operations | Subtotal
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	14	(20)
Level 3 | Continuing Operations | GMIB reinsurance contracts
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	27	(842)
OCI	0	0
Level 3 | Continuing Operations | Separate Accounts Assets
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	7	7
Net Derivative Gains (Losses)	0	0
OCI	0	0
Level 3 | Continuing Operations | GMxB derivative features liability
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	(409)	440
OCI	0	0
Level 3 | Continuing Operations | Total
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	7	7
Net Derivative Gains (Losses)	(382)	(402)
OCI	$ 14	$ (20)

FAIR VALUE DISCLOSURES - Quanta

FAIR VALUE DISCLOSURES - Quantative Information About Level 3 (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	$ (8,000,000)	$ 87,000,000
Level 3 | Corporate | Matrix pricing model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Assets, fair value	96,000,000		$ 93,000,000
Level 3 | Corporate | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Assets, fair value	$ 891,000,000		881,000,000
Level 3 | Corporate | Minimum | Matrix pricing model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Spread over benchmark	0.0015
Level 3 | Corporate | Maximum | Matrix pricing model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Spread over benchmark	0.0580
Level 3 | Corporate | Weighted Average | Matrix pricing model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Spread over benchmark	0.0109
Level 3 | Separate Accounts assets | Third party appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Assets, fair value	$ 359,000,000		352,000,000
Level 3 | Separate Accounts assets | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Assets, fair value	$ 1,000,000		$ 1,000,000
Spread over benchmark	0.0248		0.0248
Level 3 | GMIB reinsurance contracts | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Assets, fair value	$ 2,009,000,000		$ 1,991,000,000
Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.01
Servicing asset, non-performance risk	0.0052		0.0074
Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0627
Servicing asset, non-performance risk	0.0129		0.0159
Level 3 | GMIBNLG | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, non-performance liability	0.010		0.019
Withdrawal rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0		0
Withdrawal rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.080		0.080
Withdrawal rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0		0
Withdrawal rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.12144		0.121
Withdrawal rate | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0		0
Withdrawal rate | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.070		0.070
Withdrawal rate | Level 3 | GIB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0		0
Withdrawal rate | Level 3 | GIB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.080		0.080
EBITDA multiple | Level 3 | Corporate | Minimum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	3.9		4.1
EBITDA multiple | Level 3 | Corporate | Maximum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	25.5		37.8
EBITDA multiple | Level 3 | Corporate | Weighted Average | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	12.7		12.1
Discount rate | Level 3 | Corporate | Minimum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	0.061		0.064
Discount rate | Level 3 | Corporate | Maximum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	0.165		0.165
Discount rate | Level 3 | Corporate | Weighted Average | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	0.106		0.107
Discount rate | Level 3 | Separate Accounts assets | Third party appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.064		0.065
Discount rate | Level 3 | Separate Accounts assets | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.048		0.051
Cash flow multiples | Level 3 | Corporate | Minimum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	1.6		1.8
Cash flow multiples | Level 3 | Corporate | Maximum | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	18		18
Cash flow multiples | Level 3 | Corporate | Weighted Average | Market comparable companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Equity security, measurement input	11.4		11.4
Cap rate | Level 3 | Separate Accounts assets | Third party appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.044		0.044
Exit capitalization rate | Level 3 | Separate Accounts assets | Third party appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.055		0.056
Utilization rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0		0
Utilization rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.160		0.160
Utilization rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0		0
Utilization rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.160		1
Utilization rate | Level 3 | GWBL/GMWB | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	1		1
Utilization rate | Level 3 | GIB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0		0
Utilization rate | Level 3 | GIB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.160		0.160
Equity volatility | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.070		0.100
Equity volatility | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.320		0.340
Equity volatility | Level 3 | GMIBNLG | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.200
Equity volatility | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.008		0.008
Equity volatility | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.262		0.262
Equity volatility | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.070		0.100
Equity volatility | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.320		0.340
Equity volatility | Level 3 | GIB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.070		0.100
Equity volatility | Level 3 | GIB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.320		0.340
Equity volatility | Level 3 | GMAB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.070		0.100
Equity volatility | Level 3 | GMAB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.320		0.340
Forfeiture rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0055
Forfeiture rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.021
Lapse rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input			0.010
Lapse rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input			0.0627
Lapse rate | Level 3 | GWBL/GMWB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.005		0.005
Lapse rate | Level 3 | GWBL/GMWB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.057		0.057
Lapse rate | Level 3 | GIB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.005		0.005
Lapse rate | Level 3 | GIB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.057		0.057
Lapse rate | Level 3 | GMAB | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.005		0.010
Lapse rate | Level 3 | GMAB | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.110		0.057
Age 0-40 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0001		0.0001
Age 0-40 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0018		0.0018
Age 0-40 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0001		0.0001
Age 0-40 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0019		0.0019
Age 41-60 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0007		0.0007
Age 41-60 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0054		0.0054
Age 41-60 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0006		0.0006
Age 41-60 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0053		0.0053
Age 61-115 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.0042		0.0042
Age 61-115 | Mortality Rate | Level 3 | GMIB reinsurance contracts | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing asset, measurement input	0.420		0.420
Age 61-115 | Mortality Rate | Level 3 | GMIBNLG | Minimum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.0041		0.0041
Age 61-115 | Mortality Rate | Level 3 | GMIBNLG | Maximum | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Servicing liability, measurement input	0.412		0.412
GIB | Level 3 | GIB | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ (44)		$ (48,000,000)
GMIBNLG | Level 3 | GMIBNLG | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	5,847		5,341,000,000
GMxB derivative features liability | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Net Derivative Gains (Losses)	0
Assets, fair value			(5,431,000,000)
Separate Accounts assets | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Net Derivative Gains (Losses)	7,000,000	7,000,000
Assets, fair value	383,000,000	357,000,000	374,000,000	$ 349,000,000
State and Political Sub-divisions | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
OCI	1,000,000	(1,000,000)
Assets, fair value	39,000,000	39,000,000	38,000,000	40,000,000
Corporate | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
OCI	9,000,000	(20,000,000)
Assets, fair value	1,169,000,000	1,229,000,000	1,174,000,000	1,139,000,000
GMIB reinsurance contracts | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Net Derivative Gains (Losses)	0	0
Assets, fair value	2,009,000,000	9,674,000,000	1,991,000,000	$ 10,488,000,000
GWBL/GMWB | Level 3 | GWBL/GMWB | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	137		130,000,000
GMAB | Level 3 | GMAB | Discounted cash flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	4		$ 7,000,000
Continuing Operations | GMxB derivative features liability | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	(409,000,000)	440,000,000
OCI	0	0
Continuing Operations | Separate Accounts assets | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	7,000,000	7,000,000
Net Derivative Gains (Losses)	0	0
OCI	0	0
Continuing Operations | State and Political Sub-divisions | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	1,000,000	(1,000,000)
Continuing Operations | Corporate | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	9,000,000	(19,000,000)
Continuing Operations | Subtotal | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	0	0
OCI	14,000,000	(20,000,000)
Continuing Operations | GMIB reinsurance contracts | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	0	0
Net Derivative Gains (Losses)	27,000,000	(842,000,000)
OCI	0	0
Continuing Operations | Total | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investment Gains (Losses), Net	7,000,000	7,000,000
Net Derivative Gains (Losses)	(382,000,000)	(402,000,000)
OCI	$ 14,000,000	$ (20,000,000)

FAIR VALUE DISCLOSURES - Carryi

FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	$ 12,100	$ 11,818
Loans to affiliates	600	600
Policyholders’ liabilities: Investment contracts	48,593	46,403
Policy loans	3,253	3,267
Loans from affiliates	0	572
Separate Accounts liabilities	118,130	108,487
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	12,100	11,818
FHLBNY Funding Agreements	4,001	4,002
Loans to affiliates	600	600
Policyholders’ liabilities: Investment contracts	1,983	1,974
Policy loans	3,253	3,267
Loans from affiliates		572
Separate Accounts liabilities	8,173	7,406
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	12,002	11,478
FHLBNY Funding Agreements	4,011	3,956
Loans to affiliates	610	603
Policyholders’ liabilities: Investment contracts	2,094	2,015
Policy loans	4,064	3,944
Loans from affiliates		572
Separate Accounts liabilities	8,173	7,406
Fair Value | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	0	0
FHLBNY Funding Agreements	0	0
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	0	0
Policy loans	0	0
Loans from affiliates		0
Separate Accounts liabilities	0	0
Fair Value | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	0	0
FHLBNY Funding Agreements	4,011	3,956
Loans to affiliates	610	603
Policyholders’ liabilities: Investment contracts	0	0
Policy loans	0	0
Loans from affiliates		572
Separate Accounts liabilities	0	0
Fair Value | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage loans on real estate	12,002	11,478
FHLBNY Funding Agreements	0	0
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	2,094	2,015
Policy loans	4,064	3,944
Loans from affiliates		0
Separate Accounts liabilities	$ 8,173	$ 7,406

LEASES - Balance Sheet Classifi

LEASES - Balance Sheet Classification (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019
Leases [Abstract]
Operating lease asset	$ 328	$ 347
Operating lease liability	$ 422	$ 439

LEASES - Lease Costs (Details)

LEASES - Lease Costs (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Leases [Abstract]
Operating lease cost	$ 53
Variable operating lease cost	3
Sublease income	(4)
Short-term lease expense	$ 1

LEASES - Lease Maturities (Deta

LEASES - Lease Maturities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Leases not yet commenced, amount	$ 10
Operating Leases:
2019	86
2020	89
2021	84
2022	81
2023	76
Thereafter	84
Total lease payments	500
Less: Interest	(78)
Present value of lease liabilities	$ 422	$ 439
Lease obligation under ASC 840
2019			$ 81
2020			74
2021			69
2022			67
2023			63
Thereafter			$ 66
Minimum
Lessee, Lease, Description [Line Items]
Operating leases not yet commenced, term	5 years
Maximum
Lessee, Lease, Description [Line Items]
Operating leases not yet commenced, term	10 years

LEASES - Supplemental Lease Inf

LEASES - Supplemental Lease Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Leases [Abstract]
Weighted-average remaining operating lease term (years)	6 years
Weighted-average discount rate for operating leases	3.15%
Operating cash flows from operating leases	$ 21
Leased assets obtained in exchange for new operating lease liabilities	$ 1

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Leases not yet commenced, amount	$ 10
Weighted-average remaining operating lease term (years)	6 years
Operating lease liability	$ 422	$ 439
Minimum
Lessee, Lease, Description [Line Items]
Weighted-average remaining operating lease term (years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Weighted-average remaining operating lease term (years)	12 years

RELATED PARTY TRANSACTIONS - TE

RELATED PARTY TRANSACTIONS - TEXTUAL (Details) - USD ($) $ in Millions	Dec. 28, 2018	Mar. 31, 2019	Mar. 31, 2018
Senior Surplus Notes
Related Party Transaction [Line Items]
Extraordinary cash dividend	$ 572
Related party transaction, rate (as a percent)	3.75%
Related party expense		$ 4
AllianceBernstein | Affiliated Entity
Related Party Transaction [Line Items]
Related party expense		$ 24	$ 21

EQUITY - Cumulative Gains (Loss

EQUITY - Cumulative Gains (Losses) (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Defined benefit pension plans	$ 7		$ 5
Accumulated other comprehensive income	12,370	$ 12,428	18,492	$ 19,492
Less: Accumulated other comprehensive (income) loss attributable to discontinued operations, net of noncontrolling interest	0		(24)
Unrealized gains (losses) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized gains (losses) on investments	280		(129)
Total accumulated other comprehensive income (loss) from continuing operations
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income	273		(134)
Accumulated other comprehensive income (loss) attributable to AXA Equitable
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income	$ 273	$ (491)	$ (158)	$ 598

EQUITY - Components of OCI, Net

EQUITY - Components of OCI, Net of Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Net unrealized gains (losses) arising during the period	$ 1,243	$ (984)
(Gains) losses reclassified into net income (loss) during the period	6	(71)
Net unrealized gains (losses) on investments	1,249	(1,055)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	485	(313)
Less: Reclassification adjustments to Net income (loss) for:	764	(742)
Amortization of net (gains) losses included in net periodic cost	0	(4)
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	0	(4)
Total other comprehensive income (loss), net of income taxes from continuing operations	764	(746)
Other comprehensive income (loss) from discontinued operations, net of income taxes	0	(10)
Other comprehensive income (loss) attributable to AXA Equitable	764	(756)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Change in unrealized gains (losses), net of adjustments, tax	200	(197)
Change in defined benefit plans, tax	0	0
Net unrealized gains (losses) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI, current period, tax	$ 1	$ (19)

COMMITMENT AND CONTINGENT LIA_3

COMMITMENT AND CONTINGENT LIABILITIES - Obligations Under Funding Agreements (Details) $ / policy in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Feb. 29, 2016$ / policy
Restructuring Cost and Reserve [Line Items]
Funding Agreement, Difference Related To Remaining Amortization	$ 11	$ 12
Unaccrued amounts of reasonably possible range of losses	95
Advances from Federal Home Loan Banks	3,990
Proceeds from FHLBank Borrowings, Financing Activities	4,470
Payments of FHLBank Borrowings, Financing Activities	4,470
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Month
Restructuring Cost and Reserve [Line Items]
Advances from Federal Home Loan Banks	1,640
Proceeds from FHLBank Borrowings, Financing Activities	4,470
Payments of FHLBank Borrowings, Financing Activities	4,470
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Five Years
Restructuring Cost and Reserve [Line Items]
Advances from Federal Home Loan Banks	1,569
Proceeds from FHLBank Borrowings, Financing Activities	0
Payments of FHLBank Borrowings, Financing Activities	0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years
Restructuring Cost and Reserve [Line Items]
Advances from Federal Home Loan Banks	781
Proceeds from FHLBank Borrowings, Financing Activities	0
Payments of FHLBank Borrowings, Financing Activities	0
Federal Home Loan Bank of New York Long-Term Funding Agreements
Restructuring Cost and Reserve [Line Items]
Advances from Federal Home Loan Banks	2,350
Proceeds from FHLBank Borrowings, Financing Activities	0
Payments of FHLBank Borrowings, Financing Activities	$ 0
Brach Family Foundation Litigation
Restructuring Cost and Reserve [Line Items]
Liability for future policy benefits, amount per policy | $ / policy			1

COMMITMENT AND CONTINGENT LIA_4

COMMITMENT AND CONTINGENT LIABILITIES - Narrative (Details) $ / policy in Millions, $ in Millions	Mar. 31, 2019USD ($)	Feb. 29, 2016$ / policy
Loss Contingencies [Line Items]
Unaccrued amounts of reasonably possible range of losses	$ 95
Brach Family Foundation Litigation
Loss Contingencies [Line Items]
Liability for future policy benefits, amount per policy | $ / policy		1
AXA
Loss Contingencies [Line Items]
Equity commitment	877
Mortgage loans on real estate	325
Affiliated Entity | AXA
Loss Contingencies [Line Items]
Equity commitment	258
Letter of Credit
Loss Contingencies [Line Items]
Remaining borrowing capacity	$ 19

DISCONTINUED OPERATIONS - Trans

DISCONTINUED OPERATIONS - Transactions Prior to Distribution (Details) - Alliance Bernstein - Discontinued Operations $ in Millions	3 Months Ended
	Mar. 31, 2018USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	$ 822
Base fees
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	568
Performance-based fees
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	6
Research services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	114
Distribution services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	108
Shareholder services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	20
Other
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	$ 6

DISCONTINUED OPERATIONS - Incom

DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net derivative gains (losses)	$ (1,555)	$ (815)
Net investment income (loss)	904	509
Investment management and service fees	248	254
Other income	10	22
Total revenues	690	1,139
Compensation and benefits	82	149
Distribution-related payments	157	160
Interest expense	4	9
Other operating costs and expenses	184	250
Total benefits and other deductions	1,680	1,512
Net income from discontinued operations, net of taxes	0	29
Less: Net income attributable to the noncontrolling interest	(2)	1
Net income (loss) attributable to AXA Equitable	$ (830)	(263)
Alliance Bernstein | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net derivative gains (losses)		2
Net investment income (loss)		39
Investment management and service fees		803
Other income		2
Total revenues		846
Compensation and benefits		344
Distribution-related payments		110
Interest expense		2
Other operating costs and expenses		189
Total benefits and other deductions		645
Income from discontinued operations, before income taxes		201
Income tax expense		(17)
Net income from discontinued operations, net of taxes		184
Less: Net income attributable to the noncontrolling interest		(155)
Net income (loss) attributable to AXA Equitable		$ 29

REVISION OF PRIOR PERIOD FINA_3

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet Disclosures (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Assets:
Deferred policy acquisition costs	$ 4,338	$ 5,011
Total Assets	211,239	199,952
Liabilities:
Future policy benefits and other policyholders' liabilities	30,294	29,808
Other liabilities	1,600	1,460
Total Liabilities	198,821	187,485
Equity:
Retained earnings	4,268	5,098
Total equity attributable to AXA Equitable	12,358	12,416
Total Equity	12,370	12,428	$ 18,492	$ 19,492
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$ 211,239	$ 199,952
As Previously Reported
Assets:
Deferred policy acquisition costs			4,826
Total Assets			222,424
Liabilities:
Future policy benefits and other policyholders' liabilities			28,374
Current and deferred income taxes			1,728
Other liabilities			3,041
Total Liabilities			202,767
Equity:
Retained earnings			8,824
Total equity attributable to AXA Equitable			15,545
Total Equity			18,633
Total Liabilities, Redeemable Noncontrolling Interest and Equity			222,424
Discontinued Operations Adjustment
Assets:
Deferred policy acquisition costs			0
Total Assets			0
Liabilities:
Future policy benefits and other policyholders' liabilities			0
Current and deferred income taxes			(432)
Other liabilities			(1,941)
Total Liabilities			0
Equity:
Retained earnings			0
Total equity attributable to AXA Equitable			0
Total Equity			0
Total Liabilities, Redeemable Noncontrolling Interest and Equity			0
As Adjusted
Assets:
Deferred policy acquisition costs			4,826
Total Assets			222,424
Liabilities:
Future policy benefits and other policyholders' liabilities			28,374
Current and deferred income taxes			1,296
Other liabilities			1,100
Total Liabilities			202,767
Equity:
Retained earnings			8,824
Total equity attributable to AXA Equitable			15,545
Total Equity			18,633
Total Liabilities, Redeemable Noncontrolling Interest and Equity			222,424
Impact of Revisions
Assets:
Deferred policy acquisition costs			(119)
Total Assets			(119)
Liabilities:
Future policy benefits and other policyholders' liabilities			(10)
Current and deferred income taxes			(38)
Other liabilities			70
Total Liabilities			22
Equity:
Retained earnings			(141)
Total equity attributable to AXA Equitable			(141)
Total Equity			(141)
Total Liabilities, Redeemable Noncontrolling Interest and Equity			(119)
As Revised
Assets:
Deferred policy acquisition costs			4,707
Total Assets			222,305
Liabilities:
Future policy benefits and other policyholders' liabilities			28,364
Current and deferred income taxes			1,258
Other liabilities			1,170
Total Liabilities			202,789
Equity:
Retained earnings			8,683
Total equity attributable to AXA Equitable			15,404
Total Equity			18,492
Total Liabilities, Redeemable Noncontrolling Interest and Equity			$ 222,305

REVISION OF PRIOR PERIOD FINA_4

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement and Comprehensinve Income Disclosures (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Policy charges and fee income	$ 859	$ 861
Net derivative gains (losses)	(1,555)	(817)
Total Revenues	690	1,139
Commissions	157	160
Interest expense	4	9
Benefits and other deductions:
Policyholders’ benefits	819	480
Interest credited to policyholders’ account balances	269	255
Other operating costs and expenses	184	250
Compensation and benefits	82	149
Amortization of deferred policy acquisition costs	165	209
Total benefits and other deductions	1,680	1,512
Income (loss) from operations, before income taxes	(990)	(373)
Income tax (expense) benefit from continuing operations	162	80
Net income (loss)		(293)
Net income (loss)	(828)	(264)
Less: Net (income) loss attributable to the noncontrolling interest	(2)	1
Net income (loss) attributable to AXA Equitable	(830)	(263)
Statements of Comprehensive Income (Loss):
Net income (loss)	(828)	(264)
Comprehensive income (loss) attributable to AXA Equitable	$ (64)	(1,020)
As Previously Reported
Revenues:
Policy charges and fee income		869
Net derivative gains (losses)		(777)
Total Revenues		2,031
Commissions		371
Interest expense		11
Benefits and other deductions:
Policyholders’ benefits		489
Interest credited to policyholders’ account balances		338
Other operating costs and expenses		440
Compensation and benefits		456
Amortization of deferred policy acquisition costs		10
Total benefits and other deductions		2,115
Income (loss) from operations, before income taxes		(84)
Income tax (expense) benefit from continuing operations		44
Net income (loss)		(40)
Net income (loss)		(40)
Net income (loss) attributable to AXA Equitable		(194)
Statements of Comprehensive Income (Loss):
Net income (loss)		(40)
Comprehensive income (loss)		(789)
Comprehensive income (loss) attributable to AXA Equitable		(950)
Gross DAC Adjustment
Revenues:
Policy charges and fee income		0
Net derivative gains (losses)		0
Total Revenues		0
Commissions		(101)
Interest expense		0
Benefits and other deductions:
Policyholders’ benefits		0
Interest credited to policyholders’ account balances		0
Other operating costs and expenses		(1)
Compensation and benefits		(33)
Amortization of deferred policy acquisition costs		135
Total benefits and other deductions		0
Income (loss) from operations, before income taxes		0
Income tax (expense) benefit from continuing operations		0
Net income (loss)		0
Net income (loss)		0
Net income (loss) attributable to AXA Equitable		0
Statements of Comprehensive Income (Loss):
Net income (loss)		0
Discontinued Operations Adjustment
Revenues:
Policy charges and fee income		0
Net derivative gains (losses)		(2)
Total Revenues		(846)
Commissions		(110)
Interest expense		(2)
Benefits and other deductions:
Policyholders’ benefits		0
Interest credited to policyholders’ account balances		0
Other operating costs and expenses		(189)
Compensation and benefits		(344)
Amortization of deferred policy acquisition costs		0
Total benefits and other deductions		(645)
Income (loss) from operations, before income taxes		(201)
Income tax (expense) benefit from continuing operations		17
Net income (loss)		(184)
Net income (loss)		(155)
Net income (loss) attributable to AXA Equitable		0
Statements of Comprehensive Income (Loss):
Net income (loss)		(155)
Comprehensive income (loss)		(162)
Comprehensive income (loss) attributable to AXA Equitable		(1)
As Adjusted
Revenues:
Policy charges and fee income		869
Net derivative gains (losses)		(779)
Total Revenues		1,185
Commissions		160
Interest expense		9
Benefits and other deductions:
Policyholders’ benefits		489
Interest credited to policyholders’ account balances		338
Other operating costs and expenses		250
Compensation and benefits		79
Amortization of deferred policy acquisition costs		145
Total benefits and other deductions		1,470
Income (loss) from operations, before income taxes		(285)
Income tax (expense) benefit from continuing operations		61
Net income (loss)		(224)
Net income (loss)		(195)
Net income (loss) attributable to AXA Equitable		(194)
Statements of Comprehensive Income (Loss):
Net income (loss)		(195)
Comprehensive income (loss)		(951)
Comprehensive income (loss) attributable to AXA Equitable		(951)
Impact of Revisions
Revenues:
Policy charges and fee income		(8)
Net derivative gains (losses)		(38)
Total Revenues		(46)
Commissions		0
Interest expense		0
Benefits and other deductions:
Policyholders’ benefits		(9)
Interest credited to policyholders’ account balances		(83)
Other operating costs and expenses		0
Compensation and benefits		70
Amortization of deferred policy acquisition costs		64
Total benefits and other deductions		42
Income (loss) from operations, before income taxes		(88)
Income tax (expense) benefit from continuing operations		19
Net income (loss)		(69)
Net income (loss)		(69)
Net income (loss) attributable to AXA Equitable		(69)
Statements of Comprehensive Income (Loss):
Net income (loss)		(69)
Comprehensive income (loss)		(69)
Comprehensive income (loss) attributable to AXA Equitable		(69)
As Revised
Revenues:
Policy charges and fee income		861
Net derivative gains (losses)		(817)
Total Revenues		1,139
Commissions		160
Interest expense		9
Benefits and other deductions:
Policyholders’ benefits		480
Interest credited to policyholders’ account balances		255
Other operating costs and expenses		250
Compensation and benefits		149
Amortization of deferred policy acquisition costs		209
Total benefits and other deductions		1,512
Income (loss) from operations, before income taxes		(373)
Income tax (expense) benefit from continuing operations		80
Net income (loss)		(293)
Net income (loss)		(264)
Net income (loss) attributable to AXA Equitable		(263)
Statements of Comprehensive Income (Loss):
Net income (loss)		(264)
Comprehensive income (loss)		(1,020)
Comprehensive income (loss) attributable to AXA Equitable		$ (1,020)

REVISION OF PRIOR PERIOD FINA_5

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Statement of Equity Disclosures (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year	$ 12,428	$ 19,492
Net income (loss)	(830)	(263)
End of year	12,370	18,492
As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(194)
End of year		18,633
Discontinued Operations Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		0
End of year		0
As Adjusted
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(194)
End of year		18,633
Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(69)
End of year		(141)
As Revised
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(263)
End of year		18,492
AXA Equitable Equity
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year	12,416	16,397
End of year	12,358	15,404
AXA Equitable Equity | As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
End of year		15,545
AXA Equitable Equity | As Adjusted
Increase (Decrease) in Stockholders' Equity [Roll Forward]
End of year		15,545
AXA Equitable Equity | Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
End of year		(141)
AXA Equitable Equity | As Revised
Increase (Decrease) in Stockholders' Equity [Roll Forward]
End of year		15,404
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year	5,098	8,938
End of year	$ 4,268	8,683
Retained Earnings | As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year		9,010
Net income (loss)		(194)
End of year		8,824
Retained Earnings | Discontinued Operations Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year		0
Net income (loss)		0
End of year		0
Retained Earnings | As Adjusted
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year		9,010
Net income (loss)		(194)
End of year		8,824
Retained Earnings | Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year		(72)
Net income (loss)		(69)
End of year		(141)
Retained Earnings | As Revised
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of year		8,938
Net income (loss)		(263)
End of year		$ 8,683

REVISION OF PRIOR PERIOD FINA_6

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow Disclosures (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Cash flow from operating activities:
Net income (loss)	[1]	$ (828)	$ (109)
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		269	255
Policy charges and fee income		(859)	(861)
Net derivative (gains) losses		1,555	815
Equity (income) loss from limited partnerships	[2]	(11)	(39)
Changes in:
Capitalization of deferred policy acquisition costs	[2]	(145)	(135)
Future policy benefits		41	(198)
Current and deferred income taxes		54	80
Other, net		(36)	12
Net cash provided by (used in) operating activities		(148)	(17)
Proceeds from the sale/maturity/prepayment of:
Trading account securities		3,376	1,683
Real estate joint ventures		1	140
Short-term investments	[2]	747	688
Payment for the purchase/origination of:
Short-term investments	[2]	(681)	(377)
Cash settlements related to derivative instruments		(978)	(503)
Other, net		97	(407)
Net cash provided by (used in) investing activities		(694)	(983)
Policyholders’ account balances:
Deposits		2,271	1,898
Withdrawals		(1,048)	(1,081)
Transfers (to) from Separate Accounts		445	452
Net Cash Provided by (Used in) Financing Activities		1,142	1,380
Transfer of assets to reinsurer	[1]		(604)
(Settlement) issuance of long-term debt	[1]		(202)
Net (income) loss attributable to the noncontrolling interest		$ 2	(1)
As Previously Reported
Cash flow from operating activities:
Net income (loss)			(40)
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances			338
Policy charges and fee income			(869)
Net derivative (gains) losses			777
Amortization and depreciation			0
Amortization of deferred sales commission			7
Other depreciation and amortization			(23)
Amortization of other intangibles			8
Equity (income) loss from limited partnerships			0
Distributions from joint ventures and limited partnerships			25
Changes in:
Reinsurance recoverable			2
Deferred policy acquisition costs			10
Capitalization of deferred policy acquisition costs			0
Future policy benefits			(191)
Current and deferred income taxes			(52)
Other, net			(122)
Net cash provided by (used in) operating activities			(21)
Proceeds from the sale/maturity/prepayment of:
Trading account securities			1,606
Real estate joint ventures			0
Short-term investments			0
Other			54
Payment for the purchase/origination of:
Short-term investments			0
Cash settlements related to derivative instruments			(14)
Change in short-term investments			396
Other, net			(560)
Net cash provided by (used in) investing activities			(639)
Policyholders’ account balances:
Deposits			2,366
Withdrawals			(1,322)
Transfers (to) from Separate Accounts			(115)
Net Cash Provided by (Used in) Financing Activities			1,040
Transfer of assets to reinsurer			0
(Settlement) issuance of long-term debt			0
Presentation Reclassifications
Cash flow from operating activities:
Net income (loss)			0
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances			0
Policy charges and fee income			0
Net derivative (gains) losses			0
Amortization and depreciation			137
Amortization of deferred sales commission			(7)
Other depreciation and amortization			23
Amortization of other intangibles			(8)
Equity (income) loss from limited partnerships			(39)
Distributions from joint ventures and limited partnerships			(25)
Changes in:
Reinsurance recoverable			0
Deferred policy acquisition costs			(10)
Capitalization of deferred policy acquisition costs			(135)
Future policy benefits			0
Current and deferred income taxes			0
Other, net			64
Net cash provided by (used in) operating activities			0
Proceeds from the sale/maturity/prepayment of:
Trading account securities			0
Real estate joint ventures			140
Short-term investments			688
Other			(140)
Payment for the purchase/origination of:
Short-term investments			(377)
Cash settlements related to derivative instruments			0
Change in short-term investments			(311)
Other, net			0
Net cash provided by (used in) investing activities			0
Policyholders’ account balances:
Deposits			0
Withdrawals			0
Transfers (to) from Separate Accounts			0
Net Cash Provided by (Used in) Financing Activities			0
Transfer of assets to reinsurer			0
(Settlement) issuance of long-term debt			0
Impact of Revisions
Cash flow from operating activities:
Net income (loss)			(69)
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances			(83)
Policy charges and fee income			8
Net derivative (gains) losses			38
Amortization and depreciation			64
Amortization of deferred sales commission			0
Other depreciation and amortization			0
Amortization of other intangibles			0
Equity (income) loss from limited partnerships			0
Distributions from joint ventures and limited partnerships			0
Changes in:
Reinsurance recoverable			(149)
Deferred policy acquisition costs			0
Capitalization of deferred policy acquisition costs			0
Future policy benefits			(7)
Current and deferred income taxes			132
Other, net			70
Net cash provided by (used in) operating activities			4
Proceeds from the sale/maturity/prepayment of:
Trading account securities			77
Real estate joint ventures			0
Short-term investments			0
Other			0
Payment for the purchase/origination of:
Short-term investments			0
Cash settlements related to derivative instruments			(489)
Change in short-term investments			(85)
Other, net			153
Net cash provided by (used in) investing activities			(344)
Policyholders’ account balances:
Deposits			(468)
Withdrawals			241
Transfers (to) from Separate Accounts			567
Net Cash Provided by (Used in) Financing Activities			340
Transfer of assets to reinsurer			202
(Settlement) issuance of long-term debt			(604)
As Revised
Cash flow from operating activities:
Net income (loss)			(109)
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances			255
Policy charges and fee income			(861)
Net derivative (gains) losses			815
Amortization and depreciation			201
Amortization of deferred sales commission			0
Other depreciation and amortization			0
Amortization of other intangibles			0
Equity (income) loss from limited partnerships			(39)
Distributions from joint ventures and limited partnerships			0
Changes in:
Reinsurance recoverable			(147)
Deferred policy acquisition costs			0
Capitalization of deferred policy acquisition costs			(135)
Future policy benefits			(198)
Current and deferred income taxes			80
Other, net			12
Net cash provided by (used in) operating activities			(17)
Proceeds from the sale/maturity/prepayment of:
Trading account securities			1,683
Real estate joint ventures			140
Short-term investments			688
Other			(86)
Payment for the purchase/origination of:
Short-term investments			(377)
Cash settlements related to derivative instruments			(503)
Change in short-term investments			0
Other, net			(407)
Net cash provided by (used in) investing activities			(983)
Policyholders’ account balances:
Deposits			1,898
Withdrawals			(1,081)
Transfers (to) from Separate Accounts			452
Net Cash Provided by (Used in) Financing Activities			1,380
Transfer of assets to reinsurer			202
(Settlement) issuance of long-term debt			(604)
Discontinued Operations | Alliance Bernstein
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Net derivative (gains) losses			(2)
Policyholders’ account balances:
Net (income) loss attributable to the noncontrolling interest			$ 155
[1]	Net income (loss) includes $155 million in the three months ended March 31, 2018 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss).
[2]	Prior period amounts have been reclassified to conform to the current period’s presentation. See Note 14 for further information.